<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4426762</article-id><article-id pub-id-type="doi">10.3389/fimmu.2015.00217</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Boer</surname><given-names>Mardi C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/215573"/></contrib><contrib contrib-type="author"><name><surname>Joosten</surname><given-names>Simone A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/147686"/></contrib><contrib contrib-type="author"><name><surname>Ottenhoff</surname><given-names>Tom H. M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/89687"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Infectious Diseases, Leiden University Medical Center</institution>, <addr-line>Leiden</addr-line>, <country>Netherlands</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Amy Rasley, Lawrence Livermore National Laboratory, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Alexis DeHaven Dunkle, Genentech, USA; Paolo Puccetti, University of Perugia, Italy</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Tom H. M. Ottenhoff, Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands, <email>t.h.m.ottenhoff@lumc.nl</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>6</volume><elocation-id>217</elocation-id><history><date date-type="received"><day>26</day><month>2</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 Boer, Joosten and Ottenhoff.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Regulatory T-cells (Tregs) act at the interface of host and pathogen interactions in human infectious diseases. Tregs are induced by a wide range of pathogens, but distinct effects of Tregs have been demonstrated for different pathogens and in different stages of infection. Moreover, Tregs that are induced by a specific pathogen may non-specifically suppress immunity against other microbes and parasites. Thus, Treg effects need to be assessed not only in homologous but also in heterologous infections and vaccinations. Though Tregs protect the human host against excessive inflammation, they probably also increase the risk of pathogen persistence and chronic disease, and the possibility of disease reactivation later in life. <italic>Mycobacterium leprae</italic> and <italic>Mycobacterium tuberculosis</italic>, causing leprosy and tuberculosis, respectively, are among the most ancient microbes known to mankind, and are master manipulators of the immune system toward tolerance and pathogen persistence. The majority of mycobacterial infections occur in settings co-endemic for viral, parasitic, and (other) bacterial coinfections. In this paper, we discuss recent insights in the activation and activity of Tregs in human infectious diseases, with emphasis on early, late, and non-specific effects in disease, coinfections, and vaccination. We highlight mycobacterial infections as important models of modulation of host responses and vaccine-induced immunity by Tregs.</p></abstract><kwd-group><kwd>regulatory T-cells</kwd><kwd>human regulatory T-cells</kwd><kwd>infection</kwd><kwd>vaccination</kwd><kwd>pathogens</kwd><kwd>tuberculosis</kwd><kwd>leprosy</kwd><kwd>BCG</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">EC FP7 NEWTBVAC</funding-source><award-id rid="cn001">HEALTH.F3.2009 241745</award-id></award-group><award-group><funding-source id="cn002">EC FP7 ADITEC</funding-source><award-id rid="cn002">HEALTH.2011.1.4-4 280873</award-id></award-group><award-group><funding-source id="cn003">EC FP7 IDEA</funding-source><award-id rid="cn003">241642</award-id></award-group><award-group><funding-source id="cn004">TBVAC2020 Horizon2020</funding-source><award-id rid="cn004">643381</award-id></award-group><award-group><funding-source id="cn005">Netherlands Organization for Scientific Research</funding-source><award-id rid="cn005">916.86.115</award-id></award-group><award-group><funding-source id="cn006">Gisela Thier Foundation of the Leiden University Medical Center</funding-source></award-group><award-group><funding-source id="cn007">Netherlands Leprosy Foundation</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="177"/><page-count count="15"/><word-count count="14348"/></counts></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>A myriad of innate and adaptive immune regulatory cells is induced upon infection, including cells of different lineages: regulatory-like macrophages, dendritic cells (DCs), NKT-cells, T-cells, B-cells, neutrophils, and mesenchymal stem cells. During the last decade, many reports have described the role of regulatory T-cells (Tregs) in infectious diseases and following vaccination. In infectious diseases, Tregs play a dual role: they benefit the host by limiting immune-mediated pathology and also facilitate chronic pathogen persistence by reducing effector immunity and clearance of infection (<xref rid="B1" ref-type="bibr">1</xref>). During acute infection, the beneficial role of Tregs seems to predominate, by regulating leukocyte in- and efflux into lymph nodes (LN) and infected sites, suppression of proliferation of infected cells, and favoring memory formation by increasing the time window of antigen availability.</p><p>Regulatory T-cells can be induced either in an antigen- and T-cell receptor (TCR)-dependent or in an antigen- and TCR-independent manner (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Specificity for self- or pathogen-derived antigens (or dual-specificity) was originally used to divide Treg populations into &#x0201c;natural&#x0201d; resp. &#x0201c;adaptive&#x0201d; Tregs, but it was recently recommended to denote Treg populations by place of induction: &#x0201c;thymus derived&#x0201d; or &#x0201c;peripherally derived,&#x0201d; or when the origin is unclear &#x0201c;Foxp3<sup>+</sup> Treg cell&#x0201d; (<xref rid="B4" ref-type="bibr">4</xref>). Designations of human Tregs are, however, complicated by the fact that, unlike murine Tregs, unique markers are lacking. In addition, non-Treg populations can express &#x0201c;Treg markers&#x0201d; such as Foxp3 and CD25 upon activation; therefore, human Tregs are preferably defined by multiple regulatory markers and/or by demonstrating suppressive activity (<xref rid="B5" ref-type="bibr">5</xref>). Human CD8<sup>+</sup> Tregs have been studied much less than CD4<sup>+</sup> Tregs (<xref rid="B5" ref-type="bibr">5</xref>), even though they were among the first described &#x0201c;suppressor cells,&#x0201d; especially in mycobacterial infections (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). The relative lack in studies on human CD8<sup>+</sup> Tregs is possibly the result of technical difficulties in isolating and assessing functions of CD8<sup>+</sup> T-cells (<xref rid="B8" ref-type="bibr">8</xref>). Notwithstanding, CD8<sup>+</sup> Tregs are re-emerging as important players in general, including in human infectious disease and following vaccination (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Once activated, Tregs can suppress pro-inflammatory cells through several mechanisms that are adaptable to the local environment (<xref rid="B9" ref-type="bibr">9</xref>). These mechanisms can mostly be divided into inhibitory cytokine production (either membrane-bound or by their release in the pericellular environment), suppression by cytolysis, metabolic disruption of pro-inflammatory cells, modulation of antigen-presenting cells (APCs), and the activity of certain Treg membrane expressed molecules (see below) (<xref rid="B10" ref-type="bibr">10</xref>). These mechanisms indeed support the concept that antigen specifically induced Tregs can cross-suppress also other cells irrespective of the presence of their cognate antigen or specificity, e.g., through the secretion of cytokines (<xref rid="B5" ref-type="bibr">5</xref>). This &#x0201c;bystander&#x0201d; or heterologous suppression can compromise immunity toward unrelated pathogens, as has been described for coinfection by helminths in diseases such as malaria and tuberculosis (TB) (<xref rid="B11" ref-type="bibr">11</xref>). Helminth coinfections can also impair the immunogenicity of vaccines such as (oral) cholera vaccination and (intradermal) BCG (<italic>Mycobacterium bovis</italic> bacillus Calmette&#x02013;Gu&#x000e9;rin) and tetanus vaccination (<xref rid="B12" ref-type="bibr">12</xref>). Several Treg-expressed molecular markers have now been implicated directly in mediating suppression, such as cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), which modulates APCs via its ligands CD80 and CD86. Tregs were shown to use trans-endocytosis of CD80 and CD86, followed by their intracellular degradation, thereby relatively depleting the APC&#x02019;s expression of essential co-stimulatory receptors for T-cell CD28 ligation (<xref rid="B13" ref-type="bibr">13</xref>). In addition, the ecto-enzyme CD39 (E-NTPDase1), which is a relatively recently discovered Treg marker, exerts its suppressive effects through breakdown of adenosine triphosphate (ATP) (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>In this paper, we will discuss the induction of Tregs (both specific and non-specific) by various pathogens as well as the functional implications of CD4<sup>+</sup> and CD8<sup>+</sup> Tregs in acute vs. chronic infectious diseases. We will discuss the role of Tregs in coinfections and highlight in particular infections with <italic>M. leprae</italic> and <italic>M. tuberculosis</italic> (Mtb), which are master manipulators of the human innate and adaptive immune response through the induction of regulatory circuits. We will discuss how the balance of pro- vs. anti-inflammatory responses could ultimately regulate pathogen persistence, and impact on the development of active vs. latent or reactivation of disease. We will also discuss the impact of Tregs on diagnosis and treatment of TB, as well as their possible impact on vaccination against TB.</p></sec><sec id="S2"><title>Mechanisms of Treg Induction by Pathogens</title><p>As a first line of host&#x02013;defense against infection, the activation of innate immune cells through pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), lectin receptors, retinoic acid-inducible gene (RIG) receptors, scavenger, and phagocytic receptors, activates these cells to phagocytose and process the pathogen, after which they migrate to the draining lymph node (DLN) and present antigen to prime na&#x000ef;ve T-cells. These cells then can differentiate into various classes of T-helper cells (Th), cytotoxic T-cells, or Tregs. Further activation and differentiation signals are provided to the T-cells upon migration into the infected tissue; these signals originate from other T-cells, activated tissue-resident APCs, or even directly from the pathogen (see below). Tissue-resident, circulating, and migrating APCs comprised heterogeneous populations, and the activation of APCs can lead to the induction of pro-inflammatory or regulatory, homeostatic T-cell responses (<xref rid="B15" ref-type="bibr">15</xref>): for example, pro-inflammatory human type-1 macrophages promote Th1-immunity and are characterized by IL-23 production and secretion of IL-12 after IFN&#x003b3; stimulation, whereas type-2 macrophages poorly express co-stimulatory molecules, produce IL-10, and induce Tregs (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>).</p><p>Modulation of macrophages and DCs toward tolerogenic subsets has been described for various pathogens: after <italic>in vitro</italic> treatment of human DCs with Japanese encephalitis virus or Mtb, DCs upregulated the inhibitory receptor PD-L1, which induced the expansion of Tregs through PD-1 ligation (<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>). These effects were mediated by the Mtb-derived protein Acr (HspX Rv2031c), which is expressed during latency: Acr induced expression of PD-L1, TIM3, IDO, and IL-10 by murine DCs and promoted the induction of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T-cells (<xref rid="B21" ref-type="bibr">21</xref>). Furthermore, APCs can be modulated through alterations in (pericellular) purinergic pathways: extracellular ATP, a pro-inflammatory danger signal, which activates the killing of Mtb in macrophages, is rapidly hydrolyzed to AMP by CD39, which is expressed by various regulatory cells (<xref rid="B14" ref-type="bibr">14</xref>). The degradation of ATP to AMP in the microenvironment was accompanied by a switch in macrophage gene expression from type 1 toward type 2, and Mtb infection actively upregulated expression of the adenosine A2A receptor on macrophages (<xref rid="B22" ref-type="bibr">22</xref>). This receptor has been described as a major immunosuppressive immune cell adenosine receptor acting through elevation of cAMP (<xref rid="B23" ref-type="bibr">23</xref>), and its expression on macrophages was central to M2-like polarization after Mtb infection (<xref rid="B22" ref-type="bibr">22</xref>). Other cell types acting as APCs were demonstrated to contribute to Treg induction: both hepatitis C virus (HCV)-infected hepatocytes and <italic>H. pylori</italic>-infected gastric epithelial cells directly induced Tregs through production of TGF-&#x003b2; (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>).</p><p>Regulatory T-cells can also be induced directly through pathogen-derived components. This has been demonstrated in several murine studies: zwitterionic capsular polysaccharides from <italic>S. pneumoniae</italic> induced CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs that were CD122<sup>LO</sup>CTLA-4<sup>+</sup>CD39<sup>+</sup>, synthesized IL-10 and TGF-&#x003b2;, and exhibited suppressive activity. This induction was independent of APCs and involved direct crosslinking of the TCR (<xref rid="B26" ref-type="bibr">26</xref>). In another murine study, proteins secreted by <italic>H. polygyrus</italic> induced Foxp3<sup>+</sup> T-cells through ligation of the TGF-&#x003b2;-receptor (<xref rid="B27" ref-type="bibr">27</xref>). The herpes virus entry mediator HVEM, a binding site for viral glycoprotein HSVgD, is upregulated on murine CD4<sup>+</sup>Foxp3<sup>+</sup> Tregs after HSV-1 infection, and activation of this receptor led to preferential expansion of Tregs (<xref rid="B28" ref-type="bibr">28</xref>). In the human situation, CD4<sup>+</sup>CD25<sup>+</sup> Tregs exhibited extended survival and increased suppressive capacity after binding HIVgp120 (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>The preferential expression of TLRs, such as TLR2, on Tregs as compared to &#x0201c;conventional&#x0201d; T-cells has been reviewed by Sutmuller and colleagues (<xref rid="B2" ref-type="bibr">2</xref>). A large variety of TLR2 ligands have been described in bacteria, including Mtb (<xref rid="B30" ref-type="bibr">30</xref>). Mtb-induced TLR-signaling in APCs leads to inhibition of the MHC-II transactivator-gene CIITA, thereby decreasing expression of MHC-II and antigen presentation (<xref rid="B30" ref-type="bibr">30</xref>). During chronic Mtb infection, prolonged TLR2 signaling (e.g., through the 19kD lipoprotein) can lead to suppressive cytokine production (<xref rid="B31" ref-type="bibr">31</xref>) and recruitment of CD4<sup>+</sup> Tregs to the lung (<xref rid="B32" ref-type="bibr">32</xref>). A role for TLR-mediated Treg induction has also been described in murine malaria: murine <italic>Plasmodium</italic>-activated DCs induced Tregs through TLR9, and TLR9<sup>(&#x02212;/&#x02212;)</sup> mice had impaired activation of Tregs, associated with a partial resistance to lethal infection (<xref rid="B33" ref-type="bibr">33</xref>). Other factors in the local environment vital for the expansion and function of Tregs include changes in metabolism (<xref rid="B34" ref-type="bibr">34</xref>), endothelial cytokine (IL-33) production and cytokine balance (IL-23:IL-33 ratio) (<xref rid="B35" ref-type="bibr">35</xref>), and metabolite products from commensal microbiota (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). Thus, specific pathogen components can skew toward Treg phenotype or function. The significance of these Tregs for the disease process, concomitant diseases, and vaccinations will be discussed further below.</p></sec><sec id="S3"><title>The Impact of Tregs in Infectious Diseases</title><sec id="S3-1"><title>Viral infections: Acute vs. chronic infectious disease</title><p>Regulatory T-cells have been found after retrovirus-, RNA virus-, and DNA virus infection in mice and humans [reviewed in Ref. (<xref rid="B3" ref-type="bibr">3</xref>); Figure <xref ref-type="fig" rid="F1">1</xref>A]. Various CD4<sup>+</sup> and CD8<sup>+</sup> Treg subsets have been identified (<xref rid="B38" ref-type="bibr">38</xref>), but mostly in chronic viral infection. Yet, in hepatitis A virus infection &#x02013; an acute inflammatory disease, usually followed by pathogen clearance &#x02013; hepatitis A virus bound to its cellular receptor (HAVCR1), which is expressed on Tregs, which resulted in inhibited Treg function and inflammation (<xref rid="B39" ref-type="bibr">39</xref>). By contrast, in acute dengue fever, Treg function and the suppression of vasoactive cytokine release were similar in acutely infected and recovered patients, such that in this case, the disproportionate activation of pro-inflammatory cells and cytokines often found in dengue fever was not explained by acute phase Treg malfunction (<xref rid="B40" ref-type="bibr">40</xref>). Thus, blockade of Tregs in acute viral infection could assist in pathogen clearance, at the cost of temporary hyper-inflammation, but not all (pathological) hyper-inflammation is associated with Treg hypo-functionality. On the other side, Tregs could also benefit the host during acute infection: first, Treg depletion in murine herpes simplex infection increased LN levels of IFN-&#x003b1; and -&#x003b3;, but infection-site-associated IFN&#x003b3; was decreased, and the arrival of DCs, NK cells, and T-cells at the infected lesion was delayed (<xref rid="B41" ref-type="bibr">41</xref>), pointing to a role for Tregs in promoting LN in- and efflux of pro-inflammatory cells (<xref rid="B42" ref-type="bibr">42</xref>). Second, Tregs may suppress infected cell proliferation at the mucosal point-of-entry to a level where infection cannot be established, which was suggested as a protective mechanism in early HIV infection (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Third, Tregs were vital in allowing memory formation through promoting antigen persistence, as was recently demonstrated in a murine West Nile virus infection model (<xref rid="B45" ref-type="bibr">45</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Main effects of Tregs as described for various pathogens</bold>. <bold>(A)</bold> Various Treg-mediated effects have been described for the various classes of pathogens; early vs. late, and heterologous suppression, are described in several taxonomies. Prominent features are noted, as well as prominent Treg markers for the various pathogens. Circles &#x0201c;CD4/CD8&#x0201d; depict the scale in reports of either CD4<sup>+</sup> or CD8<sup>+</sup> Tregs in literature for the various classes. <bold>(B)</bold> Treg effects on TB-vaccine immunogenicity are displayed in a similar fashion. BCG immunogenicity may be decreased by or inversely related to BCG-induced Tregs, or may be suppressed by heterogenic Tregs. Treg induction has also been described in various TB-vaccine candidate trials. BCG&#x02009;=&#x02009;<italic>Mycobacterium bovis</italic> bacillus Calmette&#x02013;Gu&#x000e9;rin; CCL4&#x02009;=&#x02009;CC chemokine ligand 4; CTLA-4&#x02009;=&#x02009;cytotoxic T-lymphocyte-associated antigen 4; LAG-3&#x02009;=&#x02009;lymphocyte activation gene-3; LN&#x02009;=&#x02009;lymph node; LTBI&#x02009;=&#x02009;latent tuberculosis infection; MDR-TB&#x02009;=&#x02009;multi-drug-resistant tuberculosis; NTM&#x02009;=&#x02009;non-tuberculous mycobacteria; TB&#x02009;=&#x02009;tuberculosis; Treg&#x02009;=&#x02009;regulatory T-cell.</p></caption><graphic xlink:href="fimmu-06-00217-g001"/></fig><p>The role of human Tregs in chronic viral infection has been more extensively delineated. A meta-analysis of 12 studies demonstrated increased CD4<sup>+</sup> Treg frequencies in chronic hepatitis B virus (HBV) infection compared to both acute infection and healthy controls, revealing a strong association of Tregs with disease progression, viral load, absence of therapy response, and risk of hepatocellular carcinoma (<xref rid="B46" ref-type="bibr">46</xref>). In chronic HCV infection, the contribution of Tregs to low inflammatory CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses has been described (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). Tregs were recruited to the liver through the Treg-attracting chemokines CCL17 and CCL22 (<xref rid="B49" ref-type="bibr">49</xref>), thereby promoting pathogen persistence. It has been argued, however, that Tregs may also be functional in limiting HCV-induced liver damage (<xref rid="B48" ref-type="bibr">48</xref>).</p><p>In chronic HIV infection, CD4<sup>+</sup> Tregs were relatively increased in the mucosa and in the circulation compared to healthy controls, but the Treg-mediated effects on anti-HIV immune responses remain a matter of debate (<xref rid="B50" ref-type="bibr">50</xref>). CD4<sup>+</sup> Tregs decreased HIV replication in T-cells <italic>in vitro</italic> through CD39-mediated ectonucleotide shifts and by transfer of cAMP through gap junctions formed with conventional T-cells (<xref rid="B43" ref-type="bibr">43</xref>). Tregs inhibited spreading of virus from DCs to T-cells through interfering with the immunological synapse (<xref rid="B51" ref-type="bibr">51</xref>). In another study, blocking of CD39 by monoclonal antibodies (mAbs) restored cytokine production by HIV-gag-stimulated CD8<sup>+</sup> T-cells (<xref rid="B52" ref-type="bibr">52</xref>). Indeed, the relative frequency of CD4<sup>+</sup>CD39<sup>+</sup> Tregs positively correlated with HIV viral load and disease progression in infected individuals (<xref rid="B53" ref-type="bibr">53</xref>). These different effects of Tregs could be explained by differentiating between acute and chronic infection, as argued in Ref. (<xref rid="B50" ref-type="bibr">50</xref>): control of viral replication by CD4<sup>+</sup>(CD39<sup>+</sup>) Tregs may be important early after infection with a limited number of infected cells (relatively high Treg: T-effector ratio), yet during chronic infection Tregs may not be able to suppress proliferation of all infected cells, and potentially become more detrimental due to dampening anti-HIV responses. This points to the need for more detailed analyses of Treg functions in acute vs. chronic (hyper-) inflammation.</p></sec><sec id="S3-2"><title>Bacterial infections: Reservoirs for Treg induction</title><p>Early vs. late effects of Tregs in bacterial infection were elegantly described in a mouse model of <italic>Salmonella (Salmonella enterica</italic> serotype Typhimurium): Tregs suppressed early protective immunity, thereby allowing for establishment of infection, yet clearance of infection at later time points corresponded with a decrease in Treg suppressive capacity (<xref rid="B54" ref-type="bibr">54</xref>). After acute infection, Treg-mediated failure to completely eradicate <italic>Salmonella</italic> may thus lead to a carrier state of persistent asymptomatic infection, resulting in a reservoir for shedding of pathogens into the environment and further infection [reviewed in Ref. (<xref rid="B55" ref-type="bibr">55</xref>)]. A carrier state of <italic>Streptococcus pneumonia</italic> in the nasopharynx was associated with increased TGF-&#x003b2; levels from nasal washes in humans, and TGF-&#x003b2; was shown to lead to Treg expansion in <italic>in vitro</italic> murine experiments (<xref rid="B56" ref-type="bibr">56</xref>). In <italic>Helicobacter pylori</italic> infection, a carrier state can last for life; and several studies have described the ability of <italic>Helicobacter pylori</italic> to induce Tregs. These Tregs were found in the circulation as well as in the gastric mucosa of both infected children and adults, and though Tregs initially can limit inflammation and therefore probably gastric ulceration, pathogen persistence could, on the other hand, lead to chronic inflammation and tumor induction (<xref rid="B57" ref-type="bibr">57</xref>) [reviewed in Ref. (<xref rid="B58" ref-type="bibr">58</xref>)].</p><p>Increasing attention has been drawn to the interplay of the immune system with non-pathogenic commensal microbiota in the intestine. Tregs can be induced by commensal microbiota, as has been demonstrated in multiple murine studies: butyrate, a metabolite from commensals, potently induced Tregs in the intestine (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>), possibly through butyrate-mediated enhanced histone H3 acetylation in the FOXP3 promoter (<xref rid="B37" ref-type="bibr">37</xref>). Polysaccharide A (PSA) from <italic>B. fragilis</italic> induced conversion of T-cells into Tregs, and cured experimental colitis (<xref rid="B59" ref-type="bibr">59</xref>). The CNRZ327-component from <italic>Lactobacillus delbrueckii</italic> induced regulatory responses in colonic tissue, but importantly also in cecal LNs and the spleen, pointing to systemic distribution of these microbiota-induced Tregs (<xref rid="B60" ref-type="bibr">60</xref>).</p><p>Raising mice in germ-free conditions decreased the number of Tregs in the gut, but the number of cutaneous Tregs was increased, possibly through loss of inhibition by pro-inflammatory cells (<xref rid="B61" ref-type="bibr">61</xref>). In any case, data on activation of Tregs by skin commensals is also emerging (<xref rid="B61" ref-type="bibr">61</xref>), and these Tregs induced by skin microbiota may modulate systemic inflammatory responses (<xref rid="B61" ref-type="bibr">61</xref>). As recently reviewed (<xref rid="B62" ref-type="bibr">62</xref>), increasing evidence reveals resident microbiota in the lungs. Though relatively low in bacterial biomass compared to the microbiota of the skin and the intestinal mucosa, these microorganisms are present in healthy lungs as they are at other mucosal surfaces, and probably differ in composition between healthy individuals and individuals with (pulmonary) disease (<xref rid="B62" ref-type="bibr">62</xref>).</p><p>Clearly, mucosal surfaces are the primary sites both for pathogenic and commensal microbiota; and induction of Tregs &#x02013; within the myriad of innate and adaptive cells &#x02013; has been described for both. Further research should elucidate local and systemic effects of Tregs induced at barrier sites in human studies, and whether systemic effects of Tregs induced by (non-pathogenic) commensals are to be expected (Figure <xref ref-type="fig" rid="F1">1</xref>A).</p></sec><sec id="S3-3"><title>Parasitic infections: Suppression across boundaries</title><p>Murine <italic>Leishmaniasis</italic> models have been pivotal in demonstrating Tregs at the site of (parasitic) infection: antigen-specific CD4<sup>+</sup>CD25<sup>+</sup> Tregs were present at the site of chronic <italic>Leishmania major</italic> infection (<xref rid="B63" ref-type="bibr">63</xref>) and retention at the infection site was dependent on expression of CD103 by CD4<sup>+</sup>CD25<sup>+</sup> Tregs (<xref rid="B64" ref-type="bibr">64</xref>). In this model, the impact of Tregs on establishment of chronic infection and reactivation of disease was elegantly demonstrated: after pathogen clearance, <italic>Leishmania</italic> super-infection led to reactivation of disease and increased Treg numbers at the primary site. Also, adoptive transfer of Tregs from infected mice into chronically infected mice caused reactivation of disease (<xref rid="B65" ref-type="bibr">65</xref>). Mechanisms of suppression included IL-10 production by Tregs as well as other mechanisms (<xref rid="B66" ref-type="bibr">66</xref>). In another study, Foxp3-negative cells were the major producers of IL-10, and anti-IL-10R mAb treatment decreased parasite burden to a greater extent compared to anti-CD25-mAb treatment (<xref rid="B67" ref-type="bibr">67</xref>). In humans, functionally suppressive CD4<sup>+</sup>CD25<sup>+</sup> Tregs have been isolated from cutaneous leishmaniasis (skin) lesions (<xref rid="B68" ref-type="bibr">68</xref>); and FOXP3 mRNA levels in skin lesions were increased in chronic compared to acute <italic>Leishmania major</italic> infection (<xref rid="B69" ref-type="bibr">69</xref>). Also in <italic>Leishmania guyanensis</italic>-induced skin lesions, FOXP3 mRNA levels were significantly higher in chronic compared to acute patients, though in both cases Tregs isolated from these lesions displayed suppressive activity <italic>in vitro</italic> (<xref rid="B70" ref-type="bibr">70</xref>). Importantly, IL-10 and FOXP3 mRNA expression in <italic>Leishmania guyanensis</italic>-infected skin lesions were associated with unresponsiveness to treatment (<xref rid="B71" ref-type="bibr">71</xref>).</p><p>Several studies have reported increased Treg frequencies in <italic>Plasmodium falciparum-</italic>infected individuals compared to asymptomatic or uninfected controls (<xref rid="B72" ref-type="bibr">72</xref>); furthermore in patients with clinically severe malaria, the frequency of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>CD127<sup>LO</sup> Treg cells correlated with levels of parasitemia and total parasite biomass (<xref rid="B73" ref-type="bibr">73</xref>). Tregs were associated with risk of malaria disease: reduced expression of CTLA-4 and FOXP3 was found in Fulani, an ethnic group in Burkina Faso relatively resistant to <italic>P. falciparum</italic> compared to Mossi (a different ethnic group from the same region) (<xref rid="B74" ref-type="bibr">74</xref>). Proliferative PBMC responses to malaria antigens from Mossi were increased following CD25<sup>+</sup>-depletion, but those from Fulani were not (<xref rid="B74" ref-type="bibr">74</xref>). In Kenyan adults with natural immunity to malaria, CD4<sup>+</sup>CD25<sup>HI</sup> T-cell frequency at enrollment was associated with the risk of developing clinical malaria during follow-up (<xref rid="B75" ref-type="bibr">75</xref>).</p><p>Many helminth parasitic infections steer immunity toward Th2 and T-regulatory responses (<xref rid="B12" ref-type="bibr">12</xref>); and murine data indicate that immune suppression is achieved through cross-mucosal induction of regulatory cytokines, regulatory DCs, macrophages, and CD4<sup>+</sup> and CD8<sup>+</sup> Tregs (<xref rid="B76" ref-type="bibr">76</xref>). In a recent study of murine <italic>Trichuris muris</italic> infection, Th2 cell proliferation was enhanced by early Treg depletion post-infection and by Treg depletion after establishment of infection (<xref rid="B77" ref-type="bibr">77</xref>). However, the ultimate effect of Tregs on pathogen persistence was clearly time dependent: both early and late Treg depletion enhanced Th2 responses and reduced Th1 responses, but while early Treg depletion resulted in enhanced clearance of infection, later, during infection, Treg depletion resulted in enhanced worm burden (<xref rid="B77" ref-type="bibr">77</xref>).</p><p>Importantly, in geohelminth-infected children <italic>in vitro</italic> depletion of CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>HI</sup> T-cells increased not only antigen-specific proliferative responses but also IFN&#x003b3;-production in response to <italic>Plasmodium-</italic>infected red blood cells (<xref rid="B11" ref-type="bibr">11</xref>). The <italic>in vivo</italic> effect of helminth coinfection on immunity against <italic>Plasmodium</italic> varies between studies, but helminth coinfection may be associated with protection against cerebral malaria, a state of severe hyper-inflammation (<xref rid="B12" ref-type="bibr">12</xref>). Latent tuberculosis infection (LTBI) individuals with hookworm (<xref rid="B78" ref-type="bibr">78</xref>) and filarial coinfection (<xref rid="B79" ref-type="bibr">79</xref>) had decreased Th1 and Th17 responses and increased Treg frequencies compared to parasite-uninfected LTBI individuals. Whether deworming has clinical impact on the course of TB disease is not clear: in TB patients with helminth coinfection, albendazole treatment decreased IL-10 levels, but there was no clinical improvement in TB after 2&#x02009;months (<xref rid="B80" ref-type="bibr">80</xref>). Since (helminth-induced) Tregs are capable of exerting non-specific suppressive responses, research in malaria and TB (diseases where strong Th2 and Th1 responses are vital, respectively) will hopefully clarify the effect of Tregs across the boundaries of disease (Figure <xref ref-type="fig" rid="F1">1</xref>A), especially in settings where coinfection of helminths with malaria and/or TB is endemic.</p></sec></sec><sec id="S4"><title>Tregs in Leprosy and Tuberculosis</title><sec id="S4-4"><title>Tregs in leprosy, an ancient disease</title><p>Leprosy, caused by <italic>M. leprae</italic>, is an ancient, chronic, disabling, but curable disease affecting the skin, the peripheral nerves, the eyes, and mucosa of the respiratory tract (<xref rid="B81" ref-type="bibr">81</xref>). The clinical spectrum of the disease ranges from tuberculoid (TT) and borderline tuberculoid (BT) to borderline lepromatous (BL) and lepromatous leprosy (LL), where TT/BT is immunologically characterized by a strong Th1 response accompanied by limited growth of the bacillus (paucibacillary leprosy), whereas BL/LL is classically characterized by a predominant Treg/Th2 response, high antibody titers, absent granuloma formation, and thus poor containment of infection and clinical deterioration (<xref rid="B82" ref-type="bibr">82</xref>).</p><p>Though the exact mechanisms ruling this spectrum have not been elucidated, it is clear that Tregs play a part, and demonstration of the suppressive activity of CD4<sup>+</sup> and CD8<sup>+</sup> Tregs isolated from the skin and circulation of LL patients were among the first reports on &#x0201c;human T-suppressor cells&#x0201d; (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). In the circulation of leprosy patients, both CD4<sup>+</sup>Foxp3<sup>+</sup> and CD8<sup>+</sup>Foxp3<sup>+</sup> T-cells were almost twofold increased compared to healthy contacts (<xref rid="B83" ref-type="bibr">83</xref>). Within the spectrum of disease, increased percentages of CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> and CD8<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> T-cells have been demonstrated in the circulation of LL patients compared to BT patients or healthy contacts (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B84" ref-type="bibr">84</xref>). Also in lepromatous lesions, Foxp3<sup>+</sup> T-cells were increasingly expressed in LL compared to TT/BT patients (<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B84" ref-type="bibr">84</xref>). Suppression of the Th1 response by Tregs was demonstrated by enhanced <italic>in vitro</italic> IFN&#x003b3;-production through depletion of CD25<sup>+</sup> cells in a subset of LL patients (<xref rid="B82" ref-type="bibr">82</xref>). Both CD4<sup>+</sup>CD25<sup>+</sup> derived IL-10 production and regulation through TGF-&#x003b2; have been described (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>).</p><p>A possible mechanism of Treg induction by <italic>M. leprae</italic>&#x02013;infected DCs is the expression of the mycobacterial cell wall component PGL-1, that by association with the complement component C3 can steer toward Treg differentiation (<xref rid="B87" ref-type="bibr">87</xref>). Type 2 anti-inflammatory (CD163<sup>+</sup>) macrophages are important Treg inducers (<xref rid="B17" ref-type="bibr">17</xref>), possibly due to the action of ROS (<xref rid="B88" ref-type="bibr">88</xref>); indeed, a regulatory phenotype was described in monocytes stimulated with <italic>M. leprae</italic> (<xref rid="B89" ref-type="bibr">89</xref>). Recently, CD68<sup>+</sup>CD163<sup>+</sup> cells were demonstrated in LL skin lesions with increased frequencies compared to BT/TT lesions (<xref rid="B82" ref-type="bibr">82</xref>). Intracellular pathways leading to enhanced Foxp3 expression in CD4<sup>+</sup> T-cells have been described in association with progression of disease toward BL/LL, in addition to low Foxp3 ubiquitination (marked for intracellular degradation) (<xref rid="B86" ref-type="bibr">86</xref>). In T-cells isolated from LL patients, Foxp3 interacted with histone deacetylases and bound directly to the promotor regions of CD25 and CTLA-4 (<xref rid="B90" ref-type="bibr">90</xref>). The importance of this transcriptional regulation by Foxp3 within the immunological spectrum of disease is further supported by the fact that not only Treg frequencies are increased in LL compared to BT patients but also the intensity of expression (mean fluorescence intensity) of Foxp3 as determined by flow cytometry (<xref rid="B83" ref-type="bibr">83</xref>).</p><p>Thus, Tregs are clearly involved in the impairment of mycobacterial control. However, this does not necessarily equate to increased suppression of Th1 over Th2 responses toward the LL pole spectrum: gene expression profiling of PBMCs isolated from TT, LL, and borderline leprosy patients revealed decreased expression of both Th1 and Th2 genes in LL patients, but enhanced expression of CTLA-4 and TGFB1 (<xref rid="B91" ref-type="bibr">91</xref>). The authors further found overexpression of CBL-B, an E3 ubiquitin-ligase that after encounter with antigen is crucial in modulating T-cells toward activation vs. anergy, dependent on the presence or absence of co-stimulatory signals (<xref rid="B92" ref-type="bibr">92</xref>). Cbl-b, TGF-&#x003b2;, and CTLA-4 expression were molecularly related, as demonstrated by the dependency of Cbl-b expression on TGF-&#x003b2; and the decreased expression of Cbl-b after treatment with CTLA-4 siRNA (<xref rid="B91" ref-type="bibr">91</xref>). Within the paradigm of a generalized suppressed peripheral T-cell response associated with LL development, Tregs could thus play an important role in inducing and maintaining low cellular immune responsiveness (Figure <xref ref-type="fig" rid="F1">1</xref>A), although their impact on humoral (mostly but not exclusively Th2 related) responses remains less clear. Further work would be needed to clarify causal relationships, e.g., if Tregs are a cause or consequence of bacterial burden in LL disease (<xref rid="B93" ref-type="bibr">93</xref>).</p></sec><sec id="S4-5"><title>Tuberculosis: Early and late effects of Tregs</title><p>Pathogen-specific Tregs were induced by Mtb as demonstrated in a murine Mtb aerosol infection model, and these Tregs delayed priming of CD4<sup>+</sup> and CD8<sup>+</sup> T-cells in the pulmonary LNs, thereby delaying migration of these cells to the lung (<xref rid="B94" ref-type="bibr">94</xref>). Tregs were demonstrated in the lung, including in granulomas (<xref rid="B95" ref-type="bibr">95</xref>), and were shown to prevent pathogen clearance (<xref rid="B96" ref-type="bibr">96</xref>). Interestingly, in contrast to <italic>Listeria monocytogenes</italic>, pathogen-specific Treg expansion could be found in LNs only after Mtb infection (<xref rid="B97" ref-type="bibr">97</xref>). Thus, Mtb-induced Tregs contribute to the delayed onset of adaptive immunity that is observed in TB compared to other diseases and which allows establishment of infection (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B99" ref-type="bibr">99</xref>). The impact of Tregs on establishment of infection was further demonstrated in a murine study, where depletion of CD25<sup>+</sup> cells early after Mtb infection &#x02013; but not during chronic infection &#x02013; decreased bacterial load and granuloma formation (<xref rid="B100" ref-type="bibr">100</xref>). However, it might also be that (pre-existing) Tregs have a beneficial role very early in infection, but also these data are only derived from animal experiments. In macaques, Tregs and IFN&#x003b3;-producing effector T-cells expanded early after pulmonary TB infection, yet <italic>in vivo</italic> depletion of both IFN&#x003b3;-producing and Tregs led to decreased resistance against granuloma progression (<xref rid="B101" ref-type="bibr">101</xref>). Analogous to the possibly beneficial role for Tregs in regulating LN in- and efflux during early murine HSV-infection (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>), it is conceivable that the presence of a very low level of (possibly pre-existing) Tregs before or in a very early state after Mtb infection might thus accommodate priming and subsequent emergence of a pro-inflammatory immune response. Clearly, further research will be needed to specify the impact of Tregs in various organs (<xref rid="B102" ref-type="bibr">102</xref>), early in (human) Mtb infection, and to differentiate their impact in early vs. chronic infection (Figure <xref ref-type="fig" rid="F1">1</xref>A).</p><p>Regulatory T-cells are also present in human Mtb infection as has been demonstrated extensively: Tregs could be isolated both from the circulation and from the site of infection in TB patients. In the circulation of TB patients, an increase in FOXP3 mRNA expression was found compared with healthy controls (<xref rid="B103" ref-type="bibr">103</xref>), and also an increase in CD4<sup>+</sup> T-cell frequencies with regulatory phenotypes was demonstrated [defined as CD4<sup>+</sup>CD25<sup>+/HI</sup> (<xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B104" ref-type="bibr">104</xref>), CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>HI</sup> (<xref rid="B105" ref-type="bibr">105</xref>, <xref rid="B106" ref-type="bibr">106</xref>), or CD4<sup>+</sup>CD25<sup>HI</sup>CD39<sup>+</sup> (<xref rid="B105" ref-type="bibr">105</xref>)]. Tregs could be isolated from various Mtb-infected sites, including bronco-alveolar lavage (BAL) fluid, ascites, pericardial fluid, and pleural fluid; and FOXP3 mRNA expression levels and CD4<sup>+</sup>CD25<sup>HI</sup> T-cell frequencies were increased stronger locally than systemically (in the circulation) (<xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B107" ref-type="bibr">107</xref>). In a study comparing TB cases with infected and uninfected TB contacts (defined by positive tuberculin-skin test (TST) and ELISPOT results), PBMCs from uninfected contacts had lower FOXP3 mRNA expression levels compared to TB cases, but higher FOXP3 expression levels compared to infected TB contacts; which according to the authors could signify migration of Tregs to the lungs during early infection, with a reappearance in the circulation during latent (established) infection (<xref rid="B108" ref-type="bibr">108</xref>). Also CD8<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> Tregs were demonstrated in the circulation and BAL fluid of TB patients (<xref rid="B107" ref-type="bibr">107</xref>); and CD8<sup>+</sup>LAG-3<sup>+</sup>CCL4<sup>+</sup> Tregs [lymphocyte activation gene-3 (LAG-3); CC chemokine ligand 4 (CCL4)] were shown by histological staining of infected LNs from TB patients (<xref rid="B109" ref-type="bibr">109</xref>). Furthermore, after stimulation with HLA-E restricted Mtb-derived peptides CD8<sup>+</sup> Tregs could be isolated from PBMCs of <italic>in vitro</italic> mycobacterial purified protein derivative (PPD)-reactive donors (<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>).</p><p>Elevated frequencies of circulating Tregs in TB patients declined during successful chemotherapy (<xref rid="B106" ref-type="bibr">106</xref>), in contrast, in patients with emerging MDR-TB circulating Treg frequencies remained persistently high (<xref rid="B106" ref-type="bibr">106</xref>). Other data on Tregs in MDR vs. normally resistant (NR)-TB are scarce and conflicting: similar frequencies of circulating CD4<sup>+</sup>Foxp3<sup>+</sup> Tregs were found in MDR-TB patients compared to (NR-)TB patients (<xref rid="B112" ref-type="bibr">112</xref>); however, in another study comparing MDR-TB, NR-TB, and non-tuberculous mycobacteria (NTM) infections, increased <italic>ex vivo</italic> frequencies of Tregs were found in MDR-TB but also in NTM infections compared to NR-TB. This may reflect chronicity of infection in MDR-TB and NTM infection, which is often treated sub-optimally; however, the contrast reported by the authors between elevated serum IL-10 levels in MDR-TB patients vs. elevated serum TGF-&#x003b2; levels in NTM-infected patients could also suggest different subsets of Tregs or different suppressive effector pathways to be involved in MDR-TB vs. NTM (<xref rid="B113" ref-type="bibr">113</xref>).</p></sec><sec id="S4-6"><title>Tuberculosis: Tregs differentiate active from latent disease</title><p>CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> Tregs are increased in frequency in active TB compared to LTBI (<xref rid="B107" ref-type="bibr">107</xref>, <xref rid="B114" ref-type="bibr">114</xref>), both in the circulation and in BAL fluid (<xref rid="B107" ref-type="bibr">107</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>A). A report on CD4<sup>+</sup>CD25<sup>+</sup>CD134<sup>+</sup> T-cells in TB demonstrated differentiation between active and latent TB solely through the presence or absence of the CD39-molecule on this subset (<xref rid="B115" ref-type="bibr">115</xref>). Stasis of mycobacterial growth in macrophages, both monocyte-derived and alveolar, was suppressed by CD4<sup>+</sup> Tregs (<xref rid="B107" ref-type="bibr">107</xref>). Depletion of CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>HI</sup> T-cells increased IFN&#x003b3; responses to the mycobacterial antigen heparin-binding hemagglutinin (HBHA) of patients with active TB <italic>in vitro</italic>, to the level observed in LTBI individuals (<xref rid="B116" ref-type="bibr">116</xref>). Treg frequency in the circulation of smear-positive TB patients was increased compared to smear-negative patients; however, this did not correlate with radiologic determination of extent of disease (<xref rid="B112" ref-type="bibr">112</xref>).</p><p>Pro-inflammatory signatures of CD8<sup>+</sup> T-cells differentiated between latent infection and active TB disease (<xref rid="B117" ref-type="bibr">117</xref>), and also <italic>in vitro</italic> an association was found between burden of infection of cells and lysis by cytotoxic CD8<sup>+</sup> T-cells (<xref rid="B118" ref-type="bibr">118</xref>). The frequency of CD8<sup>+</sup> T-cells producing IL-10 or TGF-&#x003b2; was increased in active TB patients compared to latently infected or control subjects (<xref rid="B119" ref-type="bibr">119</xref>). In this study, CD8<sup>+</sup>, CD8<sup>+</sup>IFN-&#x003b3;<sup>+</sup>, and CD8<sup>+</sup>IL-17<sup>+</sup> T-cell numbers were similar between groups, and were &#x02013; interestingly &#x02013; not dependent on sputum bacillary load, while sputum bacillary load was positively associated with specific regulatory cytokine expression in CD8<sup>+</sup> T-cells, and negatively associated with CD8<sup>+</sup> granzyme B expression (<xref rid="B119" ref-type="bibr">119</xref>). However, in another study, the frequency of CD8<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> Tregs did not differ between active vs. latent TB, or between cells isolated from the circulation vs. cells isolated from BAL fluid (<xref rid="B107" ref-type="bibr">107</xref>). The differences between these reports may be explicated by differences in regulatory markers that were studied, or by methods that were used: in the former study, cells were stimulated with Mtb specific antigen for 96&#x02009;h, while in the latter study, cells were PPD-stimulated for 12&#x02009;h. CD8<sup>+</sup> Tregs are relatively understudied compared to CD4<sup>+</sup> Tregs in mycobacterial infection (<xref rid="B5" ref-type="bibr">5</xref>), and this clearly points to the need for more (uniform) research into these possibly important regulators and/or markers of activity of disease. Of note, CD8<sup>+</sup> Tregs were found at the disease site in mice, and progression of disease correlated with accumulation of IL-10-secreting CD8<sup>+</sup> T-cells in granulomas (<xref rid="B120" ref-type="bibr">120</xref>).</p><p>Instead of being a steady state of infection, latent TB comprises a dynamic spectrum with supposedly increasing rates of subclinical Mtb replication and inflammation extending eventually to active TB. Serial IGRA testing has been proposed as an indicator of human host resistance in latent TB. Using serial testing, a consistently negative test in TB-exposed individuals would likely indicate strong resistance to infection, a consistently positive test (recent) active infection, and (repeated) test conversions (positive to negative, possibly followed by conversion, etc.) changing dynamics of infection and control of bacterial load. In a comparison of T-cell subsets between IGRA-consistently positive and consistently negative TB-case contacts, CD4<sup>+</sup>Foxp3<sup>+</sup> and CD4<sup>+</sup>CTLA-4<sup>+</sup> Tregs were increased in TB-case contacts with consistently positive IGRA-tests, possibly indicating Treg interference with host resistance in the development of active infection (<xref rid="B121" ref-type="bibr">121</xref>).</p></sec><sec id="S4-7"><title>Tuberculosis: Tregs in extra-pulmonary disease</title><p>A minority of TB cases present with extra-pulmonary disease or extra-pulmonary involvement following pulmonary infection, and it is assumed that this represents failure of the immune system to contain infection (<xref rid="B122" ref-type="bibr">122</xref>). Multiple studies indicate involvement of Tregs in dissemination of disease (Figure <xref ref-type="fig" rid="F1">1</xref>A). An increase in FOXP3 mRNA expression has been described in PBMCs from patients with extra-pulmonary TB (disseminated and lymphatic TB) compared to pulmonary TB (<xref rid="B103" ref-type="bibr">103</xref>). In a comparison of TB pleural effusion and miliary TB, representing in this case containment vs. dissemination of disease, elevated FOXP3 mRNA expression levels and frequencies of CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup> T-cells were found in cells isolated from miliary disease sites (<xref rid="B123" ref-type="bibr">123</xref>). Another study confirmed an increase in CD4<sup>+</sup> Treg frequencies in patients previously treated for extra-pulmonary TB compared to pulmonary TB, but reported an analogous increase in CD4<sup>+</sup> activation markers (<xref rid="B124" ref-type="bibr">124</xref>). In TB pleurisy, CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>HI</sup> Treg frequencies were increased in pleural fluid compared to the circulation (<xref rid="B125" ref-type="bibr">125</xref>, <xref rid="B126" ref-type="bibr">126</xref>), and Tregs suppressed IFN&#x003b3;-expression in CD4<sup>+</sup> and CD8<sup>+</sup> T-cells (<xref rid="B126" ref-type="bibr">126</xref>). Pleural CD39<sup>+</sup> Tregs inhibited generation of Th17 cells, which could be reversed <italic>in vitro</italic> by antagonizing TGF-&#x003b2; through the addition of latency-associated peptide (LAP) (<xref rid="B127" ref-type="bibr">127</xref>). Mtb infection of the pleurae favored Treg migration into the pleural exudate when compared to other causes of pleurisy: tuberculous pleural fluid, but not effusions from other bacterial origin, or transudates, had high concentrations of the chemoattractant CCL22, which is chemotactic for Treg migration <italic>in vitro</italic>, and an increase in CD4<sup>+</sup>CD25<sup>HI</sup> T-cell frequency compared to the circulation (<xref rid="B125" ref-type="bibr">125</xref>). Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on pleural mesothelial cells regulated migration of leukocytes from the circulation into the pleural fluid; however, these molecules also seemed to favor (non-antigen-specific) expansion of Tregs (<xref rid="B128" ref-type="bibr">128</xref>).</p><p>In TB lymphadenitis in children, CD4<sup>+</sup>Foxp3<sup>+</sup> T-cells were demonstrated in the LNs, and quantitative mRNA analysis demonstrated induction of TGF&#x003b2; and IL13, but not of IFN&#x003b3;, TNF&#x003b1;, or IL-17 (<xref rid="B129" ref-type="bibr">129</xref>). Data on frequency and function of Tregs in other forms of TB disease, such as bone TB, urogenital TB, or TB of the central nervous system (CNS) are scarce. It is, however, conceivable that the interplay of Tregs and Mtb may differ in infections at immune-privileged sites, such as the CNS or the eye. The assessment of anti-inflammatory mechanisms could be highly relevant in regard to CNS-immune reconstitution syndromes, given their often disastrous outcomes (<xref rid="B130" ref-type="bibr">130</xref>). Several studies have associated plasma biomarkers and CD4<sup>+</sup> T-cell activation with the development of HIV-associated immune reconstitution inflammatory syndromes (IRIS), but did not find an association with (CD4<sup>+</sup>) Treg frequencies, both in the development of cryptococcal-IRIS disease (<xref rid="B131" ref-type="bibr">131</xref>) and TB-IRIS disease (<xref rid="B131" ref-type="bibr">131</xref>, <xref rid="B132" ref-type="bibr">132</xref>). TB-IRIS may either be &#x0201c;unmasking&#x0201d; (of an occult infection) or &#x0201c;paradoxical&#x0201d; (worsening of a known infection during retroviral treatment) hyper-inflammation: decreased serum IL-10 levels were found in paradoxical compared to unmasking syndromes (<xref rid="B133" ref-type="bibr">133</xref>). Interestingly, this might represent Treg function, not Treg phenotype: a study in patients developing symptoms of <italic>Mycobacterium avium</italic> and <italic>intracellulare</italic> complex-infection, following commencement of retroviral treatment, reported a significant expansion of CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>+</sup>CD127<sup>LO</sup> Tregs, but reduced functional capacity and diminished IL-10 secretion of these cells in <italic>in vitro</italic> suppression assays (<xref rid="B134" ref-type="bibr">134</xref>).</p></sec><sec id="S4-8"><title>Tuberculosis: Tregs in the clinic</title><p>Tregs may interfere with clinical diagnosis of TB (Figure <xref ref-type="fig" rid="F1">1</xref>A). Classically, diagnosing TB has relied for decades on the TST, testing cell-mediated immunity against intradermally injected Mtb-derived tuberculin PPD. Skin anergy is defined as the absence of dermal reactivity in otherwise confirmed Mtb infection. <italic>In vitro</italic> PPD stimulation of cells isolated from PPD-reactive TB patients induced both IL-10 and IFN&#x003b3;-production; however, cells from anergic TB patients produced only IL-10 but not IFN&#x003b3; (<xref rid="B135" ref-type="bibr">135</xref>). Reduced levels of IFN&#x003b3; and IL-2, and increased levels of IL-10 in anergic compared to PPD-reactive TB patients were confirmed in another study. This anergy was found only after <italic>in vitro</italic> stimulation with PPD &#x02013; but not unrelated antigens, indicating an antigen-specific anergic reaction (<xref rid="B136" ref-type="bibr">136</xref>). Suppression of IL-2- and TNF&#x003b1;-production was accompanied by CD8<sup>+</sup> T-cell expansion and high levels of IL-10 in anergic TB patients, and CD8<sup>+</sup> T-cell depletion and blocking of IL-10 reversed this suppression (<xref rid="B137" ref-type="bibr">137</xref>).</p><p>A direct effect of Treg-mediated suppression on interferon-&#x003b3; release assays (IGRAs), such as the in-tube QuantiFERON Test, has so far not been established. Nevertheless, several studies have described &#x0201c;rescue&#x0201d; of mycobacterial-specific IFN&#x003b3; production by Treg depletion in Mtb-infected individuals (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>, <xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B138" ref-type="bibr">138</xref>). Interestingly, depletion of CD25<sup>+</sup> T-cells increased IFN&#x003b3; production by PBMCs in Mtb-infected individuals, but did not increase the production of IL-17A (<xref rid="B114" ref-type="bibr">114</xref>). Yet, pleural CD39<sup>+</sup> Tregs (CD4<sup>+</sup>CD25<sup>+</sup>CD39<sup>+</sup>CD127<sup>&#x02212;</sup>) inhibited Th17 differentiation (<xref rid="B127" ref-type="bibr">127</xref>), and an inverse correlation between production of IL-17A and CD39-expressing Tregs has been described after vaccination (<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B140" ref-type="bibr">140</xref>). CD39 expression on Tregs may thus be more closely linked to suppression of IL-17 production compared to cells expressing CD25, but this needs further clarification. Also the extent of TB infection as determined by chest X-ray (CXR) scoring was associated with T-cell modulation: in a study dividing patients by severity of disease by CXR, double-negative (DN, CD4<sup>&#x02212;</sup>CD8<sup>&#x02212;</sup>) TCR&#x003b3;&#x003b4; T-cells from patients with severe disease displayed a modulatory profile with high IL-10 production, in contrast to patients with less severe disease, where TCR&#x003b3;&#x003b4; DN T-cells displayed a pro-inflammatory cytokine profile with high IFN&#x003b3; (<xref rid="B141" ref-type="bibr">141</xref>).</p><p>During TB therapy, circulating CD4<sup>+</sup> Treg frequencies declined as mentioned; however, this was only noted following chemotherapy for pulmonary TB (Figure <xref ref-type="fig" rid="F1">1</xref>A) (<xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B142" ref-type="bibr">142</xref>, <xref rid="B143" ref-type="bibr">143</xref>). In contrast, an increase was noted during extra-pulmonary TB treatment (<xref rid="B143" ref-type="bibr">143</xref>, <xref rid="B144" ref-type="bibr">144</xref>). Differences between forms of disease possibly represent differences in compartmentalization of Tregs, or heterogeneous kinetics of Treg contraction following decrease of bacterial burden. TB patients in which MDR-TB emerged during therapy had persistent circulating Treg frequencies (<xref rid="B106" ref-type="bibr">106</xref>), which could be analogous to a phenomenon observed during IFN&#x003b1; therapy for chronic HBV infection: therapy non-responders were characterized by an increase in CD4<sup>+</sup>CD25<sup>+</sup> T-cells and IL-10-producing cells (<xref rid="B145" ref-type="bibr">145</xref>). Thus, circulating Treg frequencies might be used as parameter of therapy response in specific states of TB disease.</p></sec></sec><sec id="S5"><title>Tregs in Vaccination Against Tuberculosis</title><p>Even in early life, immunoregulatory mechanisms, including Tregs, may dampen vaccine-induced immunity (<xref rid="B146" ref-type="bibr">146</xref>). We describe here how immunogenicity of TB vaccines may be influenced by Tregs, induced by the vaccination itself, by closely related pathogens, or induced by unrelated pathogens (Figure <xref ref-type="fig" rid="F1">1</xref>B). <italic>M. bovis</italic> BCG, the only available vaccine against TB, is a live bacterial vaccine aimed at inducing effective T-cell responses, yet BCG itself also induces Tregs (<xref rid="B5" ref-type="bibr">5</xref>). This ability to induce Tregs could limit its ability to induce optimal protective immunity against TB; it is, however, conceivable that future medicine may be able to tailor BCG-induced Tregs to regulate hyperinflammation.</p><sec id="S5-9"><title>Tregs induced by vaccination: <italic>M. bovis Bacillus</italic> Calmette&#x02013;Gu&#x000e9;rin</title><p>Bacillus Calmette&#x02013;Gu&#x000e9;rin, the only licensed vaccine against TB since 1921, was derived from virulent <italic>M. bovis</italic> by years of continuous <italic>in vitro</italic> passage. Estimates are that BCG has been given &#x0003e;3 billion times since its introduction, and it is part of the WHO Expanded Program for Immunization (EPI). BCG was used in one of the first experiments establishing the idea of &#x0201c;suppressor cells&#x0201d; interfering with control of infection: transfer of thymocytes from BCG-immunized rats suppressed immune responses in na&#x000ef;ve recipient rats against new BCG infection (<xref rid="B147" ref-type="bibr">147</xref>). Though BCG-vaccination induces CD4<sup>+</sup> and CD8<sup>+</sup> effector T-cell responses in newborns (<xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B149" ref-type="bibr">149</xref>) and protects them from disseminated forms of disease, it does not induce consistent protection against pulmonary TB, especially in adults (<xref rid="B150" ref-type="bibr">150</xref>). We have previously hypothesized that one explanation for this lack of protection is the induction of Tregs by the vaccine among various other hypotheses (<xref rid="B5" ref-type="bibr">5</xref>). In a large cohort of 5675 South-African infants who had been vaccinated at birth, stimulation of whole blood with mycobacterial antigens at 10&#x02009;weeks of age resulted in production of IFN&#x003b3; or IL-10, but not both (<xref rid="B151" ref-type="bibr">151</xref>). CD4<sup>+</sup>CD25<sup>+</sup> Treg cells were demonstrated in another study in BCG-vaccinated infants, and depletion of these Treg cells resulted in lower IL-10 levels in PPD-stimulated cell cultures (<xref rid="B152" ref-type="bibr">152</xref>). IL-10-producing CD4<sup>+</sup> T-cells have been demonstrated in previously BCG-vaccinated adult donors, and <italic>in vitro</italic> suppression of target cell proliferation could be reversed by a blocking &#x003b1;IL-10-antibody (<xref rid="B153" ref-type="bibr">153</xref>).</p><p>CD8<sup>+</sup> Tregs are generally less studied compared to CD4<sup>+</sup> Tregs, especially in infectious diseases (<xref rid="B5" ref-type="bibr">5</xref>). We have previously studied the presence, phenotype, and suppressive activity of CD8<sup>+</sup> Treg cells among live BCG-stimulated PBMCs of <italic>in vitro</italic> PPD-responsive donors. Surprisingly, we found a significantly higher expression of regulatory markers on live (but not killed) BCG-activated CD8<sup>+</sup> T-cells compared to CD4<sup>+</sup> T-cells, and there was significant enrichment of CD8<sup>+</sup> Treg cells within the BCG-activated CD25<sup>+</sup> T-cell compartment (<xref rid="B154" ref-type="bibr">154</xref>). Also, suppressive activity was dominantly present in live BCG-activated CD8<sup>+</sup>, but not in live BCG-activated CD4<sup>+</sup> T-cells (<xref rid="B154" ref-type="bibr">154</xref>). CD8<sup>+</sup> Treg cells isolated from live BCG-stimulated PBMCs were enriched for expression of LAG-3 and CCL4, co-expressed CD25 and Foxp3, and inhibited Th1 cell proliferation (<xref rid="B109" ref-type="bibr">109</xref>). Inhibition was partly mediated by secretion of CCL4, which reduced Ca<sup>2+</sup>-influx early after TCR triggering (<xref rid="B109" ref-type="bibr">109</xref>). We have additionally described expression of CD39 on live BCG-activated CD8<sup>+</sup> Treg cells, and a direct involvement of CD39 in mediating suppression by CD8<sup>+</sup> Tregs, as both the chemical CD39 antagonist ARL 67156 and a blocking &#x003b1;CD39-antibody were able to partly inhibit the suppressive activity of CD8<sup>+</sup>CD39<sup>+</sup> Tregs (<xref rid="B155" ref-type="bibr">155</xref>). Of note, CD8<sup>+</sup> Tregs could only be demonstrated in donors primed <italic>in vivo</italic> with mycobacteria, indicating a memory recall response following <italic>in vitro</italic> BCG stimulation. Taken together, our work identified at least two different mechanisms by which BCG-activated CD8<sup>+</sup> Tregs could inhibit Th1 responses, via CCL4 and via CD39. Despite the above findings and despite the fact that CD8 was originally identified as a marker of Treg cells, then coined T-suppressor cells, pathogen-activated CD8<sup>+</sup> Tregs still remain significantly understudied compared to CD4<sup>+</sup> Tregs. It is important to note here that <italic>in vitro</italic> stimulation with live BCG preferentially activated CD8<sup>+</sup> Tregs (<xref rid="B154" ref-type="bibr">154</xref>), while stimulation with killed BCG (or PPD) seems to activate different populations.</p></sec><sec id="S5-10"><title>Tregs induced by new TB-candidate vaccines</title><p>Regulatory T-cell induction has been demonstrated in several TB-vaccine candidate trials. After M72/AS01-vaccination of South-African healthy adults, Tregs expanded concurrently with cytokine-producing pro-inflammatory CD4<sup>+</sup> T-cells (<xref rid="B156" ref-type="bibr">156</xref>). Circulating CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T-cells were demonstrated after vaccination with another TB-vaccine candidate, modified vaccinia Ankara-85A (MVA85A). Interestingly, CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T-cells were increased in recipients with low antigen 85A-specific IFN&#x003b3;-responses compared to high IFN&#x003b3;-responders (<xref rid="B157" ref-type="bibr">157</xref>). Also, the frequency of CD4<sup>+</sup>CD25<sup>+</sup>CD39<sup>+</sup> T-cells was inversely related to IL-17A production <italic>in vitro</italic> (<xref rid="B139" ref-type="bibr">139</xref>). IL2RA mRNA expression on the day of vaccination and CTLA-4 expression 2&#x02009;days after vaccination inversely correlated with the magnitude of the IFN&#x003b3; ELISPOT response induced by MVA85A vaccination in healthy British adults, pointing to a possible role for Tregs very early or even before vaccination (<xref rid="B157" ref-type="bibr">157</xref>). In African infants vaccinated with MVA85A, an early and strong innate response was associated with enhanced IFN&#x003b3; ELISPOT responses; thus, the authors concluded that Treg modulation of vaccine responses could differ between populations, and that more research is needed to explain these differences and the impact on vaccine efficacy (<xref rid="B158" ref-type="bibr">158</xref>). Assessment should, however, include possible dissimilarities between long-term effects of Tregs and early after vaccination.</p></sec><sec id="S5-11"><title>Other Tregs can modulate TB-vaccine-induced responses</title><p>Regulatory T-cells induced by other microbes can likely alter immunogenicity of TB vaccines. Exposure to environmental mycobacteria may decrease TB-vaccine efficacy through cross-reaction of antigens (<xref rid="B94" ref-type="bibr">94</xref>). Pre-existing immune responses can either &#x0201c;block&#x0201d; or &#x0201c;mask&#x0201d; the BCG-induced immune response, possibly explaining the decreased vaccine efficacy of BCG in developing countries, where there is a higher prevalence of environmental mycobacteria (<xref rid="B159" ref-type="bibr">159</xref>). Another potential explanation for decreased vaccine efficacy is induction of Tregs by environmental mycobacteria (<xref rid="B160" ref-type="bibr">160</xref>). Priming mice with <italic>M. chelonae</italic> before BCG-vaccination increased Foxp3 expression on BCG-specific CD4<sup>+</sup>CD25<sup>+</sup> T-cells compared to non-sensitized mice, and CD4<sup>+</sup>CD25<sup>+</sup> T-cells of sensitized mice decreased immune responses <italic>in vitro</italic> (<xref rid="B161" ref-type="bibr">161</xref>). Adoptive transfer of CD4<sup>+</sup>CD25<sup>+</sup> T-cells into na&#x000ef;ve mice suppressed IL-2-production in the lungs, and enhanced IL-10 after BCG-vaccination (<xref rid="B161" ref-type="bibr">161</xref>). Suppression after murine sensitization was reversed by a blocking &#x003b1;CD25-mAb during challenge, indicating active involvement of cross-reactive Tregs during vaccination (<xref rid="B162" ref-type="bibr">162</xref>).</p><p>Modulation of DC TLRs by helminth molecules lead to increased Th2 and Treg responses, which possibly decreases vaccine efficacy in developing countries, where also the majority of the one billion helminth-infected people live (<xref rid="B12" ref-type="bibr">12</xref>). Tregs induced by helminths in mucosa-associated lymphoid tissue (MALT) may migrate to other sites, exerting non-specific suppressive effects and preventing clearance of Mtb at distant sites as well (<xref rid="B163" ref-type="bibr">163</xref>). Although the frequency of CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>HI</sup> T-cells was similar in helminth-infected and non-infected Indonesian children, BCG-specific (and as mentioned, also <italic>Plasmodium falciparum</italic>-specific) proliferative responses were increased after depletion of CD4<sup>+</sup>CD25<sup>HI</sup> T-cells in helminth-infected children only, pointing to differences in suppressive capacity induced by helminth infection (<xref rid="B11" ref-type="bibr">11</xref>). Deworming increased BCG immunogenicity <italic>in vivo</italic> and was accompanied by changes in TGF-&#x003b2;, but notably not by changes in Th2 cytokines (<xref rid="B164" ref-type="bibr">164</xref>).</p></sec><sec id="S5-12"><title>Modulating the modulators: Future prospects for Tregs in TB-vaccination</title><p>The ability of BCG to induce Tregs may in the future be exploited to benefit the human host in the contexts of auto-immune and/or hyper-inflammation-related diseases. This has been noted in a murine model of Parkinson&#x02019;s disease, where protection against nerve damage was induced by BCG-vaccination through Tregs (<xref rid="B165" ref-type="bibr">165</xref>). Also in experimental auto-immune encephalomyelitis, myelin oligodendrocyte glycoprotein-specific IFN&#x003b3;-producing CD4<sup>+</sup> T-cells, and both specific and non-specific CD4<sup>+</sup>IL-17<sup>+</sup> T-cells in the CNS, were suppressed by cerebral BCG infection (<xref rid="B166" ref-type="bibr">166</xref>). Other murine studies have demonstrated BCG-induced suppression of asthma responses and dampening of colitis (<xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B168" ref-type="bibr">168</xref>). Further research will hopefully elucidate if and how these findings can be translated to the human situation.</p><p>Interestingly, mucosal vaccination of macaques with a vaccine consisting of inactivated simian immunodeficiency virus (SIV) and a live bacterial adjuvant (BCG or <italic>Lactobacillus</italic>) generated HLA-E restricted, non-cytolytic CD8<sup>+</sup> Tregs (<xref rid="B169" ref-type="bibr">169</xref>). After challenge with SIV infection, these CD8<sup>+</sup> Tregs suppressed proliferation of infected CD4<sup>+</sup> T-cells, thereby protecting almost all vaccinated macaques for up to 4&#x02009;years after vaccination (<xref rid="B169" ref-type="bibr">169</xref>). As mentioned, in acute viral infection, Tregs could have a beneficial role to play, such as in acute SIV/HIV infection where Tregs decrease proliferation of infected cells at mucosal surfaces (<xref rid="B44" ref-type="bibr">44</xref>).</p><p>In a TB-vaccination context, however, it may be crucial to avoid excessive Treg induction by the vaccine. Analogous to the reduced burden of TB observed in mice following treatment with chemical compounds inhibiting Treg and Th2 induction prior to infection (<xref rid="B170" ref-type="bibr">170</xref>), a similar approach was tested in murine BCG-vaccination: chemical inhibition of Treg induction increased BCG-mediated protection against pulmonary TB in mice and favored central-memory T-cell induction (long-lived vaccine responses) (<xref rid="B171" ref-type="bibr">171</xref>). Blocking the IL-10-receptor with an &#x003b1;IL-10-receptor antibody increased BCG-induced Th1, Th17, innate lymphoid IFN&#x003b3;, and IL-17 responses in mice, leading to enhanced protection against TB (<xref rid="B172" ref-type="bibr">172</xref>). An additional, important role for IL-22 producing NK cells through lysing of CD4<sup>+</sup> Tregs was described, and addition of IL-22 also increased Th1 vaccine-induced responses (<xref rid="B173" ref-type="bibr">173</xref>). In contrast, only moderate efficacy of treatment with a blocking &#x003b1;CD25-antibody on BCG-vaccine efficacy was described (<xref rid="B174" ref-type="bibr">174</xref>). It is possible that blocking CD25 results in partial Treg depletion while other Treg subsets could survive during such treatment. However, CD25 is expressed also by activated T-helper cells such that CD25-depletion may additionally also deplete essential effector cells of protective immunity. Regardless, even after selective deletion of all Foxp3<sup>+</sup> cells, homeostatic expansion may occur from a small subset of remaining Tregs (<xref rid="B175" ref-type="bibr">175</xref>). Since various Treg marker-expressing subsets exist, this points to the importance of assessing the dynamics and fluidity of various subsets within the Treg compartment, in order to improve vaccine design by effective modulation of Treg activity and function. Compounds inhibiting Treg induction or blocking &#x0201c;upstream&#x0201d; signaling through the IL-10-receptor could improve vaccine efficacy. Other options would include the addition of adjuvant antagonists of chemokine receptors expressed by Tregs, as described for a CCR4 antagonist that blocked CD4<sup>+</sup> Tregs and increased <italic>in vitro</italic> responses to MVA85A and recombinant HBV surface antigen vaccination (<xref rid="B176" ref-type="bibr">176</xref>), or the inclusion of TLR-agonists combined with agents selectively blocking TLR-induced anti-inflammatory signaling pathways in DCs (<xref rid="B177" ref-type="bibr">177</xref>). Future studies may integrate these findings to increase TB-vaccine-induced protective immunity through manipulation of the manipulators, and hopefully translate these findings ultimately to the human situation.</p></sec></sec><sec id="S6"><title>Concluding Remarks and Future Directions</title><p>For many pathogens, induction, expansion, recruitment, or inhibition of Tregs has been demonstrated. <italic>Mycobacterium leprae</italic> and <italic>Mycobacterium tuberculosis</italic> are master manipulators of human immunity and are able to establish chronic infection among others by activating immune regulation. The effects of Tregs impact on clinical symptoms and performance of immunodiagnostic assays, differ in acute vs. chronic diseases and can suppress protective immunity and vaccine immunogenicity. Importantly, this can partly be the result of cross-suppression from Tregs induced by unrelated pathogens, possibly even by non-pathogenic microbes. This is particularly important in endemic settings, e.g., settings endemic for both helminths, TB, malaria, and HIV.</p><p>Through precisely (and timely) targeted Treg manipulation, vaccine-induced protective immunity may be enhanced. Most data are necessarily derived from murine studies, and need to be translated to the human situation. This should also offer opportunities for new immunotherapeutic vaccines for the treatment of inflammatory disorders, e.g., auto-immune diseases, and for the design of vaccines aimed at interfering with acute (viral) infection. Through manipulating the manipulators, increased immunity against infectious diseases may be achieved.</p></sec><sec id="S7"><title>Author Contributions</title><p>All authors fulfill the criteria for authorship.</p></sec><sec id="S8"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We acknowledge EC FP7 NEWTBVAC (contract no. HEALTH.F3.2009 241745), EC FP7 ADITEC (contract no. HEALTH.2011.1.4-4 280873), EC FP7 IDEA (Grant agreement no. 241642), and TBVAC2020 Horizon2020 (contract no. 643381) (the text represents the authors&#x02019; views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), The Netherlands Organization for Scientific Research (VENI grant 916.86.115), the Gisela Thier Foundation of the Leiden University Medical Center, and the Netherlands Leprosy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Tarbell</surname><given-names>K</given-names></name></person-group>. <article-title>Regulatory T cells in the control of host-microorganism interactions</article-title>. <source>Annu Rev Immunol</source> (<year>2009</year>) <volume>27</volume>:<fpage>551</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132723</pub-id><?supplied-pmid 19302048?><pub-id pub-id-type="pmid">19302048</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutmuller</surname><given-names>RP</given-names></name><name><surname>Morgan</surname><given-names>ME</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Grauer</surname><given-names>O</given-names></name><name><surname>Adema</surname><given-names>GJ</given-names></name></person-group>. <article-title>Toll-like receptors on regulatory T cells: expanding immune regulation</article-title>. <source>Trends Immunol</source> (<year>2006</year>) <volume>27</volume>:<fpage>387</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2006.06.005</pub-id><?supplied-pmid 16814607?><pub-id pub-id-type="pmid">16814607</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maizels</surname><given-names>RM</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name></person-group><article-title>Regulatory T cells in infection</article-title>. <source>Adv Immunol</source> (<year>2011</year>) <volume>112</volume>:<fpage>73</fpage>&#x02013;<lpage>136</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-387827-4.00003-6</pub-id><pub-id pub-id-type="pmid">22118407</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname><given-names>AK</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Campbell</surname><given-names>DJ</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Hori</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Regulatory T cells: recommendations to simplify the nomenclature</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>307</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ni.2554</pub-id><pub-id pub-id-type="pmid">23507634</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>. <article-title>Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination</article-title>. <source>Hum Immunol</source> (<year>2008</year>) <volume>69</volume>:<fpage>760</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/j.humimm.2008.07.017</pub-id><?supplied-pmid 18835413?><pub-id pub-id-type="pmid">18835413</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Elferink</surname><given-names>DG</given-names></name><name><surname>Klatser</surname><given-names>PR</given-names></name><name><surname>de Vries</surname><given-names>RR</given-names></name></person-group>. <article-title>Cloned suppressor T cells from a lepromatous leprosy patient suppress <italic>Mycobacterium leprae</italic> reactive helper T cells</article-title>. <source>Nature</source> (<year>1986</year>) <volume>322</volume>:<fpage>462</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/322462a0</pub-id><?supplied-pmid 2426597?><pub-id pub-id-type="pmid">2426597</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Mehra</surname><given-names>V</given-names></name><name><surname>Nelson</surname><given-names>EE</given-names></name><name><surname>Fan</surname><given-names>XD</given-names></name><name><surname>Rea</surname><given-names>TH</given-names></name><etal/></person-group>
<article-title>Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions</article-title>. <source>Nature</source> (<year>1986</year>) <volume>322</volume>:<fpage>459</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1038/322459a0</pub-id><?supplied-pmid 2942780?><pub-id pub-id-type="pmid">2942780</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapp</surname><given-names>JA</given-names></name><name><surname>Bucy</surname><given-names>RP</given-names></name></person-group>. <article-title>CD8+ suppressor T cells resurrected</article-title>. <source>Hum Immunol</source> (<year>2008</year>) <volume>69</volume>:<fpage>715</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.humimm.2008.07.018</pub-id><?supplied-pmid 18817830?><pub-id pub-id-type="pmid">18817830</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>JB</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group>. <article-title>Multiple treg suppressive modules and their adaptability</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<fpage>178</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2012.00178</pub-id><?supplied-pmid 22754556?><pub-id pub-id-type="pmid">22754556</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignali</surname><given-names>DA</given-names></name><name><surname>Collison</surname><given-names>LW</given-names></name><name><surname>Workman</surname><given-names>CJ</given-names></name></person-group>
<article-title>How regulatory T cells work</article-title>. <source>Nat Rev Immunol</source> (<year>2008</year>) <volume>8</volume>:<fpage>523</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="doi">10.1038/nri2343</pub-id><pub-id pub-id-type="pmid">18566595</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wammes</surname><given-names>LJ</given-names></name><name><surname>Hamid</surname><given-names>F</given-names></name><name><surname>Wiria</surname><given-names>AE</given-names></name><name><surname>de Gier</surname><given-names>B</given-names></name><name><surname>Sartono</surname><given-names>E</given-names></name><name><surname>Maizels</surname><given-names>RM</given-names></name><etal/></person-group>
<article-title>Regulatory T cells in human geohelminth infection suppress immune responses to BCG and <italic>Plasmodium falciparum</italic></article-title>. <source>Eur J Immunol</source> (<year>2010</year>) <volume>40</volume>:<fpage>437</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200939699</pub-id><?supplied-pmid 20063313?><pub-id pub-id-type="pmid">20063313</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Riet</surname><given-names>E</given-names></name><name><surname>Hartgers</surname><given-names>FC</given-names></name><name><surname>Yazdanbakhsh</surname><given-names>M</given-names></name></person-group>. <article-title>Chronic helminth infections induce immunomodulation: consequences and mechanisms</article-title>. <source>Immunobiology</source> (<year>2007</year>) <volume>212</volume>:<fpage>475</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.imbio.2007.03.009</pub-id><?supplied-pmid 17544832?><pub-id pub-id-type="pmid">17544832</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>OS</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Attridge</surname><given-names>K</given-names></name><name><surname>Manzotti</surname><given-names>C</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><etal/></person-group>
<article-title>Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4</article-title>. <source>Science</source> (<year>2011</year>) <volume>332</volume>:<fpage>600</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1126/science.1202947</pub-id><?supplied-pmid 21474713?><pub-id pub-id-type="pmid">21474713</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname><given-names>KM</given-names></name><name><surname>Deaglio</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Friedman</surname><given-names>D</given-names></name><name><surname>Strom</surname><given-names>TB</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name></person-group>. <article-title>CD39 and control of cellular immune responses</article-title>. <source>Purinergic Signal</source> (<year>2007</year>) <volume>3</volume>:<fpage>171</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1007/s11302-006-9050-y</pub-id><?supplied-pmid 18404431?><pub-id pub-id-type="pmid">18404431</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name></person-group>. <article-title>Protective and pathogenic functions of macrophage subsets</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>:<fpage>723</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1038/nri3073</pub-id><?supplied-pmid 21997792?><pub-id pub-id-type="pmid">21997792</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verreck</surname><given-names>FA</given-names></name><name><surname>de Boer</surname><given-names>T</given-names></name><name><surname>Langenberg</surname><given-names>DM</given-names></name><name><surname>Hoeve</surname><given-names>MA</given-names></name><name><surname>Kramer</surname><given-names>M</given-names></name><name><surname>Vaisberg</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2004</year>) <volume>101</volume>:<fpage>4560</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0400983101</pub-id><?supplied-pmid 15070757?><pub-id pub-id-type="pmid">15070757</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>de Boer</surname><given-names>T</given-names></name><name><surname>Walburg</surname><given-names>KV</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van</surname><given-names>MK</given-names></name><name><surname>Geluk</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>2220</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.3.2220</pub-id><?supplied-pmid 18641362?><pub-id pub-id-type="pmid">18641362</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Hegde</surname><given-names>P</given-names></name><name><surname>Lecerf</surname><given-names>M</given-names></name><name><surname>Nain</surname><given-names>M</given-names></name><name><surname>Kaur</surname><given-names>M</given-names></name><name><surname>Kalia</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Japanese encephalitis virus expands regulatory T cells by increasing the expression of PD-L1 on dendritic cells</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>:<fpage>1363</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201343701</pub-id><?supplied-pmid 24643627?><pub-id pub-id-type="pmid">24643627</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinath</surname><given-names>J</given-names></name><name><surname>Maddur</surname><given-names>MS</given-names></name><name><surname>Kaveri</surname><given-names>SV</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name><name><surname>Bayry</surname><given-names>J</given-names></name></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells</article-title>. <source>J Infect Dis</source> (<year>2012</year>) <volume>205</volume>:<fpage>694</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir820</pub-id><pub-id pub-id-type="pmid">22238465</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Periasamy</surname><given-names>S</given-names></name><name><surname>Dhiman</surname><given-names>R</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Paidipally</surname><given-names>P</given-names></name><name><surname>Tvinnereim</surname><given-names>A</given-names></name><name><surname>Bandaru</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Infect Dis</source> (<year>2011</year>) <volume>203</volume>:<fpage>1256</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jir011</pub-id><?supplied-pmid 21383382?><pub-id pub-id-type="pmid">21383382</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>KF</given-names></name><name><surname>Amir</surname><given-names>M</given-names></name><name><surname>Gurram</surname><given-names>RK</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Arora</surname><given-names>A</given-names></name><name><surname>Rajagopal</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Latency-associated protein Acr1 impairs dendritic cell maturation and functionality: a possible mechanism of immune evasion by <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>209</volume>:<fpage>1436</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit595</pub-id><?supplied-pmid 24218502?><pub-id pub-id-type="pmid">24218502</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois-Colas</surname><given-names>N</given-names></name><name><surname>Petit-Jentreau</surname><given-names>L</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Durand</surname><given-names>S</given-names></name><name><surname>Soubigou</surname><given-names>G</given-names></name><name><surname>Lecointe</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Extracellular adenosine triphosphate affects the response of human macrophages infected with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>210</volume>:<fpage>824</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiu135</pub-id><?supplied-pmid 24604822?><pub-id pub-id-type="pmid">24604822</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>A</given-names></name><name><surname>Sitkovsky</surname><given-names>M</given-names></name></person-group>. <article-title>Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage</article-title>. <source>Nature</source> (<year>2001</year>) <volume>414</volume>:<fpage>916</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1038/414916a</pub-id><?supplied-pmid 11780065?><pub-id pub-id-type="pmid">11780065</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CH</given-names></name><name><surname>Kassel</surname><given-names>R</given-names></name><name><surname>Tacke</surname><given-names>RS</given-names></name><name><surname>Hahn</surname><given-names>YS</given-names></name></person-group>. <article-title>HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta</article-title>. <source>PLoS One</source> (<year>2010</year>) <volume>5</volume>:<fpage>e12154</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0012154</pub-id><?supplied-pmid 20730048?><pub-id pub-id-type="pmid">20730048</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beswick</surname><given-names>EJ</given-names></name><name><surname>Pinchuk</surname><given-names>IV</given-names></name><name><surname>Earley</surname><given-names>RB</given-names></name><name><surname>Schmitt</surname><given-names>DA</given-names></name><name><surname>Reyes</surname><given-names>VE</given-names></name></person-group>. <article-title>Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during <italic>Helicobacter pylori</italic> infection</article-title>. <source>Infect Immun</source> (<year>2011</year>) <volume>79</volume>:<fpage>2737</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01146-10</pub-id><?supplied-pmid 21482686?><pub-id pub-id-type="pmid">21482686</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Fabri</surname><given-names>M</given-names></name><name><surname>Zingarelli</surname><given-names>A</given-names></name><name><surname>Kubacki</surname><given-names>T</given-names></name><name><surname>Meemboor</surname><given-names>S</given-names></name><name><surname>Groneck</surname><given-names>L</given-names></name><etal/></person-group>
<article-title><italic>Streptococcus pneumoniae</italic> serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking</article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000596</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000596</pub-id><?supplied-pmid 19779562?><pub-id pub-id-type="pmid">19779562</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grainger</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Hewitson</surname><given-names>JP</given-names></name><name><surname>McSorley</surname><given-names>HJ</given-names></name><name><surname>Harcus</surname><given-names>Y</given-names></name><name><surname>Filbey</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>2331</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20101074</pub-id><?supplied-pmid 20876311?><pub-id pub-id-type="pmid">20876311</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Rajasagi</surname><given-names>NK</given-names></name><name><surname>Veiga-Parga</surname><given-names>T</given-names></name><name><surname>Rouse</surname><given-names>BT</given-names></name></person-group>. <article-title>Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection</article-title>. <source>Microbes Infect</source> (<year>2014</year>) <volume>16</volume>:<fpage>648</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.micinf.2014.06.005</pub-id><?supplied-pmid 24956596?><pub-id pub-id-type="pmid">24956596</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Cloyd</surname><given-names>MW</given-names></name></person-group>. <article-title>HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression</article-title>. <source>Int Immunol</source> (<year>2009</year>) <volume>21</volume>:<fpage>283</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1093/intimm/dxn146</pub-id><?supplied-pmid 19208751?><pub-id pub-id-type="pmid">19208751</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>CV</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group>. <article-title>Regulation of antigen presentation by <italic>Mycobacterium tuberculosis</italic>: a role for Toll-like receptors</article-title>. <source>Nat Rev Microbiol</source> (<year>2010</year>) <volume>8</volume>:<fpage>296</fpage>&#x02013;<lpage>307</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro2321</pub-id><?supplied-pmid 20234378?><pub-id pub-id-type="pmid">20234378</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraav</surname><given-names>I</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group>. <article-title>Outcome of <italic>Mycobacterium tuberculosis</italic> and toll-like receptor interaction: immune response or immune evasion?</article-title>
<source>Immunol Cell Biol</source> (<year>2014</year>) <volume>92</volume>:<fpage>741</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/icb.2014.52</pub-id><?supplied-pmid 24983458?><pub-id pub-id-type="pmid">24983458</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>A</given-names></name><name><surname>Konowich</surname><given-names>J</given-names></name><name><surname>Salgame</surname><given-names>P</given-names></name></person-group>. <article-title>Host defense and recruitment of Foxp3(+) T regulatory cells to the lungs in chronic <italic>Mycobacterium tuberculosis</italic> infection requires toll-like receptor 2</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003397</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003397</pub-id><?supplied-pmid 23785280?><pub-id pub-id-type="pmid">23785280</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hisaeda</surname><given-names>H</given-names></name><name><surname>Tetsutani</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Moriya</surname><given-names>C</given-names></name><name><surname>Tu</surname><given-names>L</given-names></name><name><surname>Hamano</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<fpage>2496</fpage>&#x02013;<lpage>503</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.180.4.2496</pub-id><?supplied-pmid 18250459?><pub-id pub-id-type="pmid">18250459</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>LA</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group>. <article-title>Metabolism of inflammation limited by AMPK and pseudo-starvation</article-title>. <source>Nature</source> (<year>2013</year>) <volume>493</volume>:<fpage>346</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1038/nature11862</pub-id><?supplied-pmid 23325217?><pub-id pub-id-type="pmid">23325217</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiering</surname><given-names>C</given-names></name><name><surname>Krausgruber</surname><given-names>T</given-names></name><name><surname>Chomka</surname><given-names>A</given-names></name><name><surname>Frohlich</surname><given-names>A</given-names></name><name><surname>Adelmann</surname><given-names>K</given-names></name><name><surname>Wohlfert</surname><given-names>EA</given-names></name><etal/></person-group>
<article-title>The alarmin IL-33 promotes regulatory T-cell function in the intestine</article-title>. <source>Nature</source> (<year>2014</year>) <volume>513</volume>:<fpage>564</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nature13577</pub-id><?supplied-pmid 25043027?><pub-id pub-id-type="pmid">25043027</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arpaia</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Dikiy</surname><given-names>S</given-names></name><name><surname>van der</surname><given-names>V</given-names></name><name><surname>deRoos</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation</article-title>. <source>Nature</source> (<year>2013</year>) <volume>504</volume>:<fpage>451</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature12726</pub-id><?supplied-pmid 24226773?><pub-id pub-id-type="pmid">24226773</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furusawa</surname><given-names>Y</given-names></name><name><surname>Obata</surname><given-names>Y</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Endo</surname><given-names>TA</given-names></name><name><surname>Nakato</surname><given-names>G</given-names></name><name><surname>Takahashi</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source>Nature</source> (<year>2013</year>) <volume>504</volume>:<fpage>446</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1038/nature12721</pub-id><?supplied-pmid 24226770?><pub-id pub-id-type="pmid">24226770</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiga-Parga</surname><given-names>T</given-names></name><name><surname>Sehrawat</surname><given-names>S</given-names></name><name><surname>Rouse</surname><given-names>BT</given-names></name></person-group>. <article-title>Role of regulatory T cells during virus infection</article-title>. <source>Immunol Rev</source> (<year>2013</year>) <volume>255</volume>:<fpage>182</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12085</pub-id><?supplied-pmid 23947355?><pub-id pub-id-type="pmid">23947355</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manangeeswaran</surname><given-names>M</given-names></name><name><surname>Jacques</surname><given-names>J</given-names></name><name><surname>Tami</surname><given-names>C</given-names></name><name><surname>Konduru</surname><given-names>K</given-names></name><name><surname>Amharref</surname><given-names>N</given-names></name><name><surname>Perrella</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans</article-title>. <source>Gastroenterology</source> (<year>2012</year>) <volume>142</volume>:<fpage>1516</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2012.02.039</pub-id><?supplied-pmid 22430395?><pub-id pub-id-type="pmid">22430395</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luhn</surname><given-names>K</given-names></name><name><surname>Simmons</surname><given-names>CP</given-names></name><name><surname>Moran</surname><given-names>E</given-names></name><name><surname>Dung</surname><given-names>NT</given-names></name><name><surname>Chau</surname><given-names>TN</given-names></name><name><surname>Quyen</surname><given-names>NT</given-names></name><etal/></person-group>
<article-title>Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>979</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20061381</pub-id><?supplied-pmid 17452519?><pub-id pub-id-type="pmid">17452519</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>JM</given-names></name><name><surname>Hsing</surname><given-names>L</given-names></name><name><surname>Pham</surname><given-names>TT</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group>. <article-title>Coordination of early protective immunity to viral infection by regulatory T cells</article-title>. <source>Science</source> (<year>2008</year>) <volume>320</volume>:<fpage>1220</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1126/science.1155209</pub-id><?supplied-pmid 18436744?><pub-id pub-id-type="pmid">18436744</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassiotis</surname><given-names>G</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group>
<article-title>Immunology. Immunity benefits from a little suppression</article-title>. <source>Science</source> (<year>2008</year>) <volume>320</volume>:<fpage>1168</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1126/science.1159090</pub-id><pub-id pub-id-type="pmid">18511677</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Fernandez</surname><given-names>ME</given-names></name><name><surname>Rueda</surname><given-names>CM</given-names></name><name><surname>Rusie</surname><given-names>LK</given-names></name><name><surname>Chougnet</surname><given-names>CA</given-names></name></person-group>. <article-title>Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism</article-title>. <source>Blood</source> (<year>2011</year>) <volume>117</volume>:<fpage>5372</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2010-12-323162</pub-id><?supplied-pmid 21436067?><pub-id pub-id-type="pmid">21436067</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>AT</given-names></name></person-group>. <article-title>Perils at mucosal front lines for HIV and SIV and their hosts</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>:<fpage>783</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1038/nri1706</pub-id><?supplied-pmid 16200081?><pub-id pub-id-type="pmid">16200081</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>JB</given-names></name><name><surname>Da</surname><given-names>CA</given-names></name><name><surname>Lund</surname><given-names>JM</given-names></name></person-group>. <article-title>Regulatory T cells shape the resident memory T cell response to virus infection in the tissues</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>683</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1202153</pub-id><?supplied-pmid 24337378?><pub-id pub-id-type="pmid">24337378</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aalaei-Andabili</surname><given-names>SH</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name></person-group>. <article-title>Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis</article-title>. <source>Vaccine</source> (<year>2012</year>) <volume>30</volume>:<fpage>5595</fpage>&#x02013;<lpage>602</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.06.063</pub-id><?supplied-pmid 22781305?><pub-id pub-id-type="pmid">22781305</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Losikoff</surname><given-names>PT</given-names></name><name><surname>Self</surname><given-names>AA</given-names></name><name><surname>Gregory</surname><given-names>SH</given-names></name></person-group>. <article-title>Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C</article-title>. <source>Virulence</source> (<year>2012</year>) <volume>3</volume>:<fpage>610</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.4161/viru.21823</pub-id><?supplied-pmid 23076334?><pub-id pub-id-type="pmid">23076334</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Self</surname><given-names>AA</given-names></name><name><surname>Losikoff</surname><given-names>PT</given-names></name><name><surname>Gregory</surname><given-names>SH</given-names></name></person-group>. <article-title>Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C</article-title>. <source>Hum Vaccin Immunother</source> (<year>2013</year>) <volume>9</volume>:<fpage>1569</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.4161/hv.24726</pub-id><?supplied-pmid 23732899?><pub-id pub-id-type="pmid">23732899</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riezu-Boj</surname><given-names>JI</given-names></name><name><surname>Larrea</surname><given-names>E</given-names></name><name><surname>Aldabe</surname><given-names>R</given-names></name><name><surname>Guembe</surname><given-names>L</given-names></name><name><surname>Casares</surname><given-names>N</given-names></name><name><surname>Galeano</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection</article-title>. <source>J Hepatol</source> (<year>2011</year>) <volume>54</volume>:<fpage>422</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/j.jhep.2010.07.014</pub-id><?supplied-pmid 21129807?><pub-id pub-id-type="pmid">21129807</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>MF</given-names></name><name><surname>Weiss</surname><given-names>L</given-names></name></person-group>. <article-title>The split personality of regulatory T cells in HIV infection</article-title>. <source>Blood</source> (<year>2013</year>) <volume>121</volume>:<fpage>29</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-07-409755</pub-id><?supplied-pmid 23043072?><pub-id pub-id-type="pmid">23043072</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Fernandez</surname><given-names>ME</given-names></name><name><surname>Joedicke</surname><given-names>JJ</given-names></name><name><surname>Chougnet</surname><given-names>CA</given-names></name></person-group>. <article-title>Regulatory T cells diminish HIV infection in dendritic cells &#x02013; conventional CD4(+) T cell clusters</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>199</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00199</pub-id><?supplied-pmid 24847325?><pub-id pub-id-type="pmid">24847325</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolova</surname><given-names>M</given-names></name><name><surname>Carriere</surname><given-names>M</given-names></name><name><surname>Jenabian</surname><given-names>MA</given-names></name><name><surname>Limou</surname><given-names>S</given-names></name><name><surname>Younas</surname><given-names>M</given-names></name><name><surname>Kok</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>CD39/adenosine pathway is involved in AIDS progression</article-title>. <source>PLoS Pathog</source> (<year>2011</year>) <volume>7</volume>:<fpage>e1002110</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002110</pub-id><?supplied-pmid 21750674?><pub-id pub-id-type="pmid">21750674</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze Zur</surname><given-names>WJ</given-names></name><name><surname>Thomssen</surname><given-names>A</given-names></name><name><surname>Hartjen</surname><given-names>P</given-names></name><name><surname>Toth</surname><given-names>I</given-names></name><name><surname>Lehmann</surname><given-names>C</given-names></name><name><surname>Meyer-Olson</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease</article-title>. <source>J Virol</source> (<year>2011</year>) <volume>85</volume>:<fpage>1287</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01758-10</pub-id><?supplied-pmid 21047964?><pub-id pub-id-type="pmid">21047964</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johanns</surname><given-names>TM</given-names></name><name><surname>Ertelt</surname><given-names>JM</given-names></name><name><surname>Rowe</surname><given-names>JH</given-names></name><name><surname>Way</surname><given-names>SS</given-names></name></person-group>. <article-title>Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent <italic>Salmonella</italic> infection</article-title>. <source>PLoS Pathog</source> (<year>2010</year>) <volume>6</volume>:<fpage>e1001043</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1001043</pub-id><?supplied-pmid 20714351?><pub-id pub-id-type="pmid">20714351</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monack</surname><given-names>DM</given-names></name></person-group>. <article-title><italic>Helicobacter</italic> and <italic>Salmonella</italic> persistent infection strategies</article-title>. <source>Cold Spring Harb Perspect Med</source> (<year>2013</year>) <volume>3</volume>:<fpage>a010348</fpage>.<pub-id pub-id-type="doi">10.1101/cshperspect.a010348</pub-id><?supplied-pmid 24296347?><pub-id pub-id-type="pmid">24296347</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neill</surname><given-names>DR</given-names></name><name><surname>Coward</surname><given-names>WR</given-names></name><name><surname>Gritzfeld</surname><given-names>JF</given-names></name><name><surname>Richards</surname><given-names>L</given-names></name><name><surname>Garcia-Garcia</surname><given-names>FJ</given-names></name><name><surname>Dotor</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Density and duration of pneumococcal carriage is maintained by transforming growth factor beta1 and T regulatory cells</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2014</year>) <volume>189</volume>:<fpage>1250</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201401-0128OC</pub-id><?supplied-pmid 24749506?><pub-id pub-id-type="pmid">24749506</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>KW</given-names></name><name><surname>Letley</surname><given-names>DP</given-names></name><name><surname>Ingram</surname><given-names>RJ</given-names></name><name><surname>Staples</surname><given-names>E</given-names></name><name><surname>Skjoldmose</surname><given-names>H</given-names></name><name><surname>Atherton</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>CCL20/CCR6-mediated migration of regulatory T cells to the <italic>Helicobacter pylori</italic>-infected human gastric mucosa</article-title>. <source>Gut</source> (<year>2014</year>) <volume>63</volume>:<fpage>1550</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2013-306253</pub-id><?supplied-pmid 24436142?><pub-id pub-id-type="pmid">24436142</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lina</surname><given-names>TT</given-names></name><name><surname>Alzahrani</surname><given-names>S</given-names></name><name><surname>Gonzalez</surname><given-names>J</given-names></name><name><surname>Pinchuk</surname><given-names>IV</given-names></name><name><surname>Beswick</surname><given-names>EJ</given-names></name><name><surname>Reyes</surname><given-names>VE</given-names></name></person-group>. <article-title>Immune evasion strategies used by <italic>Helicobacter pylori</italic></article-title>. <source>World J Gastroenterol</source> (<year>2014</year>) <volume>20</volume>:<fpage>12753</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.v20.i36.12753</pub-id><?supplied-pmid 25278676?><pub-id pub-id-type="pmid">25278676</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname><given-names>JL</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>. <article-title>Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>12204</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0909122107</pub-id><?supplied-pmid 20566854?><pub-id pub-id-type="pmid">20566854</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>RC</given-names></name><name><surname>Gomes-Santos</surname><given-names>AC</given-names></name><name><surname>Garcias</surname><given-names>MT</given-names></name><name><surname>de</surname><given-names>AM</given-names></name><name><surname>Diniz</surname><given-names>LT</given-names></name><name><surname>Mariadassou</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium <italic>Lactobacillus delbrueckii</italic></article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>:<fpage>e85923</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0085923</pub-id><?supplied-pmid 24465791?><pub-id pub-id-type="pmid">24465791</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamizo</surname><given-names>S</given-names></name><name><surname>Egawa</surname><given-names>G</given-names></name><name><surname>Honda</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>S</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Kabashima</surname><given-names>K</given-names></name></person-group>
<article-title>Commensal bacteria and cutaneous immunity</article-title>. <source>Semin Immunopathol</source> (<year>2014</year>) <volume>37</volume>:<fpage>73</fpage>&#x02013;<lpage>80</lpage><pub-id pub-id-type="doi">10.1007/s00281-014-0452-6</pub-id><pub-id pub-id-type="pmid">25326105</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsland</surname><given-names>BJ</given-names></name><name><surname>Gollwitzer</surname><given-names>ES</given-names></name></person-group>
<article-title>Host-microorganism interactions in lung diseases</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<fpage>827</fpage>&#x02013;<lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nri3769</pub-id><pub-id pub-id-type="pmid">25421702</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suffia</surname><given-names>IJ</given-names></name><name><surname>Reckling</surname><given-names>SK</given-names></name><name><surname>Piccirillo</surname><given-names>CA</given-names></name><name><surname>Goldszmid</surname><given-names>RS</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name></person-group>. <article-title>Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens</article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>:<fpage>777</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20052056</pub-id><?supplied-pmid 16533885?><pub-id pub-id-type="pmid">16533885</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suffia</surname><given-names>I</given-names></name><name><surname>Reckling</surname><given-names>SK</given-names></name><name><surname>Salay</surname><given-names>G</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name></person-group>. <article-title>A role for CD103 in the retention of CD4+CD25+ Treg and control of <italic>Leishmania</italic> major infection</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>5444</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.9.5444</pub-id><?supplied-pmid 15845457?><pub-id pub-id-type="pmid">15845457</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>S</given-names></name><name><surname>Reckling</surname><given-names>SK</given-names></name><name><surname>Piccirillo</surname><given-names>CA</given-names></name><name><surname>Sacks</surname><given-names>D</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name></person-group>. <article-title>Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity</article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>200</volume>:<fpage>201</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20040298</pub-id><?supplied-pmid 15263027?><pub-id pub-id-type="pmid">15263027</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Piccirillo</surname><given-names>CA</given-names></name><name><surname>Mendez</surname><given-names>S</given-names></name><name><surname>Shevach</surname><given-names>EM</given-names></name><name><surname>Sacks</surname><given-names>DL</given-names></name></person-group>. <article-title>CD4+CD25+ regulatory T cells control <italic>Leishmania</italic> major persistence and immunity</article-title>. <source>Nature</source> (<year>2002</year>) <volume>420</volume>:<fpage>502</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature01152</pub-id><?supplied-pmid 12466842?><pub-id pub-id-type="pmid">12466842</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagase</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>KM</given-names></name><name><surname>Anderson</surname><given-names>CF</given-names></name><name><surname>Noben-Trauth</surname><given-names>N</given-names></name></person-group>. <article-title>Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in <italic>Leishmania</italic> major susceptibility</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>2435</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2435</pub-id><?supplied-pmid 17675505?><pub-id pub-id-type="pmid">17675505</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campanelli</surname><given-names>AP</given-names></name><name><surname>Roselino</surname><given-names>AM</given-names></name><name><surname>Cavassani</surname><given-names>KA</given-names></name><name><surname>Pereira</surname><given-names>MS</given-names></name><name><surname>Mortara</surname><given-names>RA</given-names></name><name><surname>Brodskyn</surname><given-names>CI</given-names></name><etal/></person-group>
<article-title>CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells</article-title>. <source>J Infect Dis</source> (<year>2006</year>) <volume>193</volume>:<fpage>1313</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1086/502980</pub-id><?supplied-pmid 16586370?><pub-id pub-id-type="pmid">16586370</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoseini</surname><given-names>SG</given-names></name><name><surname>Javanmard</surname><given-names>SH</given-names></name><name><surname>Zarkesh</surname><given-names>SH</given-names></name><name><surname>Khamesipour</surname><given-names>A</given-names></name><name><surname>Rafiei</surname><given-names>L</given-names></name><name><surname>Karbalaie</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to <italic>Leishmania</italic> major</article-title>. <source>J Res Med Sci</source> (<year>2012</year>) <volume>17</volume>:<fpage>513</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 23626625?><pub-id pub-id-type="pmid">23626625</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourreau</surname><given-names>E</given-names></name><name><surname>Ronet</surname><given-names>C</given-names></name><name><surname>Darcissac</surname><given-names>E</given-names></name><name><surname>Lise</surname><given-names>MC</given-names></name><name><surname>Sainte</surname><given-names>MD</given-names></name><name><surname>Clity</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to <italic>Leishmania guyanensis</italic></article-title>. <source>Infect Immun</source> (<year>2009</year>) <volume>77</volume>:<fpage>1465</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01398-08</pub-id><?supplied-pmid 19168733?><pub-id pub-id-type="pmid">19168733</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourreau</surname><given-names>E</given-names></name><name><surname>Ronet</surname><given-names>C</given-names></name><name><surname>Darsissac</surname><given-names>E</given-names></name><name><surname>Lise</surname><given-names>MC</given-names></name><name><surname>Marie</surname><given-names>DS</given-names></name><name><surname>Clity</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>In leishmaniasis due to <italic>Leishmania guyanensis</italic> infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment</article-title>. <source>J Infect Dis</source> (<year>2009</year>) <volume>199</volume>:<fpage>576</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1086/596508</pub-id><?supplied-pmid 19125672?><pub-id pub-id-type="pmid">19125672</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>DS</given-names></name><name><surname>Schofield</surname><given-names>L</given-names></name></person-group>. <article-title>Natural regulatory T cells in malaria: host or parasite allies?</article-title>
<source>PLoS Pathog</source> (<year>2010</year>) <volume>6</volume>:<fpage>e1000771</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000771</pub-id><?supplied-pmid 20442856?><pub-id pub-id-type="pmid">20442856</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minigo</surname><given-names>G</given-names></name><name><surname>Woodberry</surname><given-names>T</given-names></name><name><surname>Piera</surname><given-names>KA</given-names></name><name><surname>Salwati</surname><given-names>E</given-names></name><name><surname>Tjitra</surname><given-names>E</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria</article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000402</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000402</pub-id><?supplied-pmid 19390618?><pub-id pub-id-type="pmid">19390618</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torcia</surname><given-names>MG</given-names></name><name><surname>Santarlasci</surname><given-names>V</given-names></name><name><surname>Cosmi</surname><given-names>L</given-names></name><name><surname>Clemente</surname><given-names>A</given-names></name><name><surname>Maggi</surname><given-names>L</given-names></name><name><surname>Mangano</surname><given-names>VD</given-names></name><etal/></person-group>
<article-title>Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to <italic>Plasmodium falciparum</italic> malaria</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2008</year>) <volume>105</volume>:<fpage>646</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0709969105</pub-id><?supplied-pmid 18174328?><pub-id pub-id-type="pmid">18174328</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todryk</surname><given-names>SM</given-names></name><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Mwangi</surname><given-names>T</given-names></name><name><surname>Plebanski</surname><given-names>M</given-names></name><name><surname>Urban</surname><given-names>B</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans</article-title>. <source>PLoS One</source> (<year>2008</year>) <volume>3</volume>:<fpage>e2027</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0002027</pub-id><?supplied-pmid 18446217?><pub-id pub-id-type="pmid">18446217</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstock</surname><given-names>JV</given-names></name><name><surname>Elliott</surname><given-names>DE</given-names></name></person-group>. <article-title>Helminth infections decrease host susceptibility to immune-mediated diseases</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>3239</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1400927</pub-id><?supplied-pmid 25240019?><pub-id pub-id-type="pmid">25240019</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawant</surname><given-names>DV</given-names></name><name><surname>Gravano</surname><given-names>DM</given-names></name><name><surname>Vogel</surname><given-names>P</given-names></name><name><surname>Giacomin</surname><given-names>P</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name><name><surname>Vignali</surname><given-names>DA</given-names></name></person-group>. <article-title>Regulatory T cells limit induction of protective immunity and promote immune pathology following intestinal helminth infection</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>2904</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1202502</pub-id><?supplied-pmid 24532574?><pub-id pub-id-type="pmid">24532574</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>PJ</given-names></name><name><surname>Anuradha</surname><given-names>R</given-names></name><name><surname>Kumaran</surname><given-names>PP</given-names></name><name><surname>Chandrasekaran</surname><given-names>V</given-names></name><name><surname>Nutman</surname><given-names>TB</given-names></name><name><surname>Babu</surname><given-names>S</given-names></name></person-group>. <article-title>Modulation of mycobacterial-specific Th1 and Th17 cells in latent tuberculosis by coincident hookworm infection</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<fpage>5161</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1203311</pub-id><?supplied-pmid 23576678?><pub-id pub-id-type="pmid">23576678</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>S</given-names></name><name><surname>Bhat</surname><given-names>SQ</given-names></name><name><surname>Kumar</surname><given-names>NP</given-names></name><name><surname>Jayantasri</surname><given-names>S</given-names></name><name><surname>Rukmani</surname><given-names>S</given-names></name><name><surname>Kumaran</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1</article-title>. <source>J Infect Dis</source> (<year>2009</year>) <volume>200</volume>:<fpage>288</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1086/599797</pub-id><?supplied-pmid 19505258?><pub-id pub-id-type="pmid">19505258</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abate</surname><given-names>E</given-names></name><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Getachew</surname><given-names>A</given-names></name><name><surname>Alemu</surname><given-names>S</given-names></name><name><surname>Diro</surname><given-names>E</given-names></name><name><surname>Britton</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomized clinical trial</article-title>. <source>Int J Parasitol</source> (<year>2014</year>) <volume>45</volume>(<issue>2&#x02013;3</issue>):<fpage>133</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijpara.2014.09.006</pub-id><?supplied-pmid 25486494?><pub-id pub-id-type="pmid">25486494</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>Report of the global forum on elimination of leprosy as a public health problem. World Health Organization, Geneva, Switzerland</source>. (<year>2006</year>).</mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobosha</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Bekele</surname><given-names>Y</given-names></name><name><surname>Zewdie</surname><given-names>M</given-names></name><name><surname>Van Der Ploeg-Van Schip</surname><given-names>JJ</given-names></name><etal/></person-group>
<article-title>T-cell regulation in lepromatous leprosy</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2014</year>) <volume>8</volume>:<fpage>e2773</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0002773</pub-id><?supplied-pmid 24722473?><pub-id pub-id-type="pmid">24722473</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>C</given-names></name><name><surname>Goncalves</surname><given-names>HS</given-names></name><name><surname>Cabral</surname><given-names>PB</given-names></name><name><surname>Pinto</surname><given-names>HC</given-names></name><name><surname>Pinto</surname><given-names>MI</given-names></name><name><surname>Camara</surname><given-names>LM</given-names></name></person-group>. <article-title>Increased frequency of CD4 and CD8 regulatory T cells in individuals under 15 years with multibacillary leprosy</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e79072</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0079072</pub-id><?supplied-pmid 24244424?><pub-id pub-id-type="pmid">24244424</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palermo</surname><given-names>ML</given-names></name><name><surname>Pagliari</surname><given-names>C</given-names></name><name><surname>Trindade</surname><given-names>MA</given-names></name><name><surname>Yamashitafuji</surname><given-names>TM</given-names></name><name><surname>Duarte</surname><given-names>AJ</given-names></name><name><surname>Cacere</surname><given-names>CR</given-names></name><etal/></person-group>
<article-title>Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy</article-title>. <source>Am J Trop Med Hyg</source> (<year>2012</year>) <volume>86</volume>:<fpage>878</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.4269/ajtmh.2012.12-0088</pub-id><?supplied-pmid 22556091?><pub-id pub-id-type="pmid">22556091</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>C</given-names></name><name><surname>Ramesh</surname><given-names>V</given-names></name><name><surname>Nath</surname><given-names>I</given-names></name></person-group>. <article-title>Increase in TGF-beta secreting CD4(+)CD25(+) FOXP3(+) T regulatory cells in anergic lepromatous leprosy patients</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2014</year>) <volume>8</volume>:<fpage>e2639</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0002639</pub-id><?supplied-pmid 24454972?><pub-id pub-id-type="pmid">24454972</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Naqvi</surname><given-names>RA</given-names></name><name><surname>Ali</surname><given-names>R</given-names></name><name><surname>Rani</surname><given-names>R</given-names></name><name><surname>Khanna</surname><given-names>N</given-names></name><name><surname>Rao</surname><given-names>DN</given-names></name></person-group>. <article-title>CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy</article-title>. <source>Mol Immunol</source> (<year>2013</year>) <volume>56</volume>:<fpage>513</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.molimm.2013.04.015</pub-id><?supplied-pmid 23911408?><pub-id pub-id-type="pmid">23911408</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callegaro-Filho</surname><given-names>D</given-names></name><name><surname>Shrestha</surname><given-names>N</given-names></name><name><surname>Burdick</surname><given-names>AE</given-names></name><name><surname>Haslett</surname><given-names>PA</given-names></name></person-group>. <article-title>A potential role for complement in immune evasion by <italic>Mycobacterium leprae</italic></article-title>. <source>J Drugs Dermatol</source> (<year>2010</year>) <volume>9</volume>:<fpage>1373</fpage>&#x02013;<lpage>82</lpage>.<?supplied-pmid 21061760?><pub-id pub-id-type="pmid">21061760</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraaij</surname><given-names>MD</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>van der Kooij</surname><given-names>SW</given-names></name><name><surname>Koekkoek</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>van den Berg</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>17686</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1012016107</pub-id><?supplied-pmid 20861446?><pub-id pub-id-type="pmid">20861446</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura</surname><given-names>DF</given-names></name><name><surname>de Mattos</surname><given-names>KA</given-names></name><name><surname>Amadeu</surname><given-names>TP</given-names></name><name><surname>Andrade</surname><given-names>PR</given-names></name><name><surname>Sales</surname><given-names>JS</given-names></name><name><surname>Schmitz</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>CD163 favors <italic>Mycobacterium leprae</italic> survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>:<fpage>2925</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201142198</pub-id><?supplied-pmid 22851198?><pub-id pub-id-type="pmid">22851198</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Naqvi</surname><given-names>RA</given-names></name><name><surname>Ali</surname><given-names>R</given-names></name><name><surname>Rani</surname><given-names>R</given-names></name><name><surname>Khanna</surname><given-names>N</given-names></name><name><surname>Rao</surname><given-names>DN</given-names></name></person-group>. <article-title>FoxP3 provides competitive fitness to CD4(+)CD25(+) T cells in leprosy patients via transcriptional regulation</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>:<fpage>431</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201343649</pub-id><?supplied-pmid 24214631?><pub-id pub-id-type="pmid">24214631</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Naqvi</surname><given-names>RA</given-names></name><name><surname>Khanna</surname><given-names>N</given-names></name><name><surname>Pathak</surname><given-names>P</given-names></name><name><surname>Rao</surname><given-names>DN</given-names></name></person-group>. <article-title>Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-beta, CTLA-4 and Cbl-b</article-title>. <source>Clin Immunol</source> (<year>2011</year>) <volume>141</volume>:<fpage>133</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.clim.2011.06.007</pub-id><?supplied-pmid 21807564?><pub-id pub-id-type="pmid">21807564</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolino</surname><given-names>M</given-names></name><name><surname>Thien</surname><given-names>CB</given-names></name><name><surname>Gruber</surname><given-names>T</given-names></name><name><surname>Hinterleitner</surname><given-names>R</given-names></name><name><surname>Baier</surname><given-names>G</given-names></name><name><surname>Langdon</surname><given-names>WY</given-names></name><etal/></person-group>
<article-title>Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>2138</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003390</pub-id><?supplied-pmid 21248250?><pub-id pub-id-type="pmid">21248250</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname><given-names>AK</given-names></name></person-group>
<article-title>A network of regulatory pathways in lepromatous leprosy</article-title>. <source>Clin Immunol</source> (<year>2011</year>) <volume>141</volume>:<fpage>127</fpage><pub-id pub-id-type="doi">10.1016/j.clim.2011.08.007</pub-id><pub-id pub-id-type="pmid">21903479</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Tucker-Heard</surname><given-names>G</given-names></name><name><surname>Kariyone</surname><given-names>A</given-names></name><name><surname>Takatsu</surname><given-names>K</given-names></name><name><surname>Urdahl</surname><given-names>KB</given-names></name></person-group>. <article-title>Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>1409</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20091885</pub-id><?supplied-pmid 20547826?><pub-id pub-id-type="pmid">20547826</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott-Browne</surname><given-names>JP</given-names></name><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Tucker-Heard</surname><given-names>G</given-names></name><name><surname>Ishida-Tsubota</surname><given-names>K</given-names></name><name><surname>Fontenot</surname><given-names>JD</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name><etal/></person-group>
<article-title>Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>2159</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20062105</pub-id><?supplied-pmid 17709423?><pub-id pub-id-type="pmid">17709423</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kursar</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Mittrucker</surname><given-names>HW</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Bonhagen</surname><given-names>K</given-names></name><name><surname>Kamradt</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Cutting edge: regulatory T cells prevent efficient clearance of <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>2661</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.5.2661</pub-id><?supplied-pmid 17312107?><pub-id pub-id-type="pmid">17312107</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Dinh</surname><given-names>C</given-names></name><name><surname>Ertelt</surname><given-names>JM</given-names></name><name><surname>Moguche</surname><given-names>AO</given-names></name><name><surname>Siddiqui</surname><given-names>I</given-names></name><name><surname>Smigiel</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>Pathogen-specific Treg cells expand early during <italic>Mycobacterium tuberculosis</italic> infection but are later eliminated in response to interleukin-12</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>1261</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.06.003</pub-id><?supplied-pmid 23791647?><pub-id pub-id-type="pmid">23791647</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>. <article-title>New pathways of protective and pathological host defense to mycobacteria</article-title>. <source>Trends Microbiol</source> (<year>2012</year>) <volume>20</volume>(<issue>9</issue>):<fpage>419</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1016/j.tim.2012.06.002</pub-id><?supplied-pmid 22784857?><pub-id pub-id-type="pmid">22784857</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>
<article-title>Cell-mediated immune responses in tuberculosis</article-title>. <source>Annu Rev Immunol</source> (<year>2009</year>) <volume>27</volume>:<fpage>393</fpage>&#x02013;<lpage>422</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132703</pub-id><pub-id pub-id-type="pmid">19302046</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozeki</surname><given-names>Y</given-names></name><name><surname>Sugawara</surname><given-names>I</given-names></name><name><surname>Udagawa</surname><given-names>T</given-names></name><name><surname>Aoki</surname><given-names>T</given-names></name><name><surname>Osada-Oka</surname><given-names>M</given-names></name><name><surname>Tateishi</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice</article-title>. <source>Int Immunol</source> (<year>2010</year>) <volume>22</volume>:<fpage>179</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.1093/intimm/dxp126</pub-id><?supplied-pmid 20139174?><pub-id pub-id-type="pmid">20139174</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Halliday</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>RC</given-names></name><etal/></person-group>
<article-title>IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>4278</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1101291</pub-id><?supplied-pmid 22474020?><pub-id pub-id-type="pmid">22474020</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratz</surname><given-names>IK</given-names></name><name><surname>Campbell</surname><given-names>DJ</given-names></name></person-group>. <article-title>Organ-specific and memory treg cells: specificity, development, function, and maintenance</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>333</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00333</pub-id><?supplied-pmid 25076948?><pub-id pub-id-type="pmid">25076948</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyot-Revol</surname><given-names>V</given-names></name><name><surname>Innes</surname><given-names>JA</given-names></name><name><surname>Hackforth</surname><given-names>S</given-names></name><name><surname>Hinks</surname><given-names>T</given-names></name><name><surname>Lalvani</surname><given-names>A</given-names></name></person-group>. <article-title>Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2006</year>) <volume>173</volume>:<fpage>803</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200508-1294OC</pub-id><?supplied-pmid 16339919?><pub-id pub-id-type="pmid">16339919</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro-Rodrigues</surname><given-names>R</given-names></name><name><surname>Resende</surname><given-names>CT</given-names></name><name><surname>Rojas</surname><given-names>R</given-names></name><name><surname>Toossi</surname><given-names>Z</given-names></name><name><surname>Dietze</surname><given-names>R</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name><etal/></person-group>
<article-title>A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis</article-title>. <source>Clin Exp Immunol</source> (<year>2006</year>) <volume>144</volume>:<fpage>25</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03027.x</pub-id><?supplied-pmid 16542361?><pub-id pub-id-type="pmid">16542361</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiacchio</surname><given-names>T</given-names></name><name><surname>Casetti</surname><given-names>R</given-names></name><name><surname>Butera</surname><given-names>O</given-names></name><name><surname>Vanini</surname><given-names>V</given-names></name><name><surname>Carrara</surname><given-names>S</given-names></name><name><surname>Girardi</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis</article-title>. <source>Clin Exp Immunol</source> (<year>2009</year>) <volume>156</volume>:<fpage>463</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.03908.x</pub-id><?supplied-pmid 19438599?><pub-id pub-id-type="pmid">19438599</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Dey</surname><given-names>AB</given-names></name><name><surname>Mohan</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>PK</given-names></name><name><surname>Mitra</surname><given-names>DK</given-names></name></person-group>. <article-title>Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e44728</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0044728</pub-id><?supplied-pmid 23028594?><pub-id pub-id-type="pmid">23028594</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>PL</given-names></name><name><surname>Binder</surname><given-names>AB</given-names></name><name><surname>Davids</surname><given-names>M</given-names></name><name><surname>Maredza</surname><given-names>A</given-names></name><name><surname>van Zyl-Smit</surname><given-names>RN</given-names></name><name><surname>Dheda</surname><given-names>K</given-names></name></person-group>. <article-title>Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2013</year>) <volume>187</volume>:<fpage>1249</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201210-1934OC</pub-id><?supplied-pmid 23590266?><pub-id pub-id-type="pmid">23590266</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burl</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>PC</given-names></name><name><surname>Jeffries</surname><given-names>DJ</given-names></name><name><surname>Holland</surname><given-names>MJ</given-names></name><name><surname>Fox</surname><given-names>A</given-names></name><name><surname>Lugos</surname><given-names>MD</given-names></name><etal/></person-group>
<article-title>FOXP3 gene expression in a tuberculosis case contact study</article-title>. <source>Clin Exp Immunol</source> (<year>2007</year>) <volume>149</volume>:<fpage>117</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2007.03399.x</pub-id><?supplied-pmid 17465993?><pub-id pub-id-type="pmid">17465993</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>de Boer</surname><given-names>T</given-names></name><name><surname>Triebel</surname><given-names>F</given-names></name><name><surname>van der Wal</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>:<fpage>8029</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0702257104</pub-id><?supplied-pmid 17483450?><pub-id pub-id-type="pmid">17483450</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>van Weeren</surname><given-names>PC</given-names></name><name><surname>Kazi</surname><given-names>F</given-names></name><name><surname>Geluk</surname><given-names>A</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity</article-title>. <source>PLoS Pathog</source> (<year>2010</year>) <volume>6</volume>:<fpage>e1000782</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000782</pub-id><?supplied-pmid 20195504?><pub-id pub-id-type="pmid">20195504</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Haks</surname><given-names>MC</given-names></name><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Dieli</surname><given-names>F</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name></person-group>. <article-title>Human CD8+ T-cells recognizing peptides from <italic>Mycobacterium tuberculosis</italic> (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset</article-title>. <source>PLoS Pathog</source> (<year>2015</year>) <volume>11</volume>(<issue>3</issue>):<fpage>e1004671</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004671</pub-id><?supplied-pmid 25803478?><pub-id pub-id-type="pmid">25803478</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Cho</surname><given-names>YJ</given-names></name><name><surname>Yoon</surname><given-names>HI</given-names></name><name><surname>Park</surname><given-names>KU</given-names></name><name><surname>Lee</surname><given-names>CT</given-names></name><etal/></person-group>
<article-title>CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2013</year>) <volume>93</volume>:<fpage>523</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2013.06.001</pub-id><?supplied-pmid 23810735?><pub-id pub-id-type="pmid">23810735</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>RO</given-names></name><name><surname>de Oliveira</surname><given-names>EB</given-names></name><name><surname>Dos</surname><given-names>SG</given-names></name><name><surname>Sperandio da Silva</surname><given-names>GM</given-names></name><name><surname>de Andrade Silva</surname><given-names>BJ</given-names></name><name><surname>Teles</surname><given-names>RM</given-names></name><etal/></person-group>
<article-title>Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients</article-title>. <source>Clin Exp Immunol</source> (<year>2013</year>) <volume>171</volume>:<fpage>210</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/cei.12007</pub-id><?supplied-pmid 23286948?><pub-id pub-id-type="pmid">23286948</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>ND</given-names></name><name><surname>Paris</surname><given-names>SC</given-names></name><name><surname>Velez</surname><given-names>VM</given-names></name><name><surname>Rojas</surname><given-names>CA</given-names></name><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>LF</given-names></name></person-group>. <article-title>Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2010</year>) <volume>90</volume>:<fpage>252</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2010.05.003</pub-id><?supplied-pmid 20594914?><pub-id pub-id-type="pmid">20594914</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Perera</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>DB</given-names></name><name><surname>Fernandez</surname><given-names>S</given-names></name><name><surname>Seddiki</surname><given-names>N</given-names></name><name><surname>Waring</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2014</year>) <volume>94</volume>:<fpage>494</fpage>&#x02013;<lpage>501</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2014.07.002</pub-id><?supplied-pmid 25095750?><pub-id pub-id-type="pmid">25095750</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Place</surname><given-names>S</given-names></name><name><surname>Verscheure</surname><given-names>V</given-names></name><name><surname>de San</surname><given-names>N</given-names></name><name><surname>Hougardy</surname><given-names>JM</given-names></name><name><surname>Schepers</surname><given-names>K</given-names></name><name><surname>Dirix</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2010</year>) <volume>182</volume>:<fpage>848</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201001-0083OC</pub-id><?supplied-pmid 20508213?><pub-id pub-id-type="pmid">20508213</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozot</surname><given-names>V</given-names></name><name><surname>Vigano</surname><given-names>S</given-names></name><name><surname>Mazza-Stalder</surname><given-names>J</given-names></name><name><surname>Idrizi</surname><given-names>E</given-names></name><name><surname>Day</surname><given-names>CL</given-names></name><name><surname>Perreau</surname><given-names>M</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic>-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease</article-title>. <source>Eur J Immunol</source> (<year>2013</year>) <volume>43</volume>:<fpage>1568</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201243262</pub-id><?supplied-pmid 23456989?><pub-id pub-id-type="pmid">23456989</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>DA</given-names></name><name><surname>Heinzel</surname><given-names>AS</given-names></name><name><surname>Gardner</surname><given-names>JM</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Alderson</surname><given-names>MR</given-names></name><name><surname>Lewinsohn</surname><given-names>DM</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic>-specific CD8+ T cells preferentially recognize heavily infected cells</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2003</year>) <volume>168</volume>:<fpage>1346</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200306-837OC</pub-id><?supplied-pmid 12969871?><pub-id pub-id-type="pmid">12969871</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>BD</given-names></name><name><surname>Trentini</surname><given-names>MM</given-names></name><name><surname>da Costa</surname><given-names>AC</given-names></name><name><surname>Kipnis</surname><given-names>A</given-names></name><name><surname>Junqueira-Kipnis</surname><given-names>AP</given-names></name></person-group>. <article-title>Different phenotypes of CD8+ T cells associated with bacterial load in active tuberculosis</article-title>. <source>Immunol Lett</source> (<year>2014</year>) <volume>160</volume>:<fpage>23</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.imlet.2014.03.009</pub-id><?supplied-pmid 24694750?><pub-id pub-id-type="pmid">24694750</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cyktor</surname><given-names>JC</given-names></name><name><surname>Carruthers</surname><given-names>B</given-names></name><name><surname>Beamer</surname><given-names>GL</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name></person-group>. <article-title>Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e58612</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0058612</pub-id><?supplied-pmid 23472214?><pub-id pub-id-type="pmid">23472214</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia Jacobo</surname><given-names>RE</given-names></name><name><surname>Serrano</surname><given-names>CJ</given-names></name><name><surname>Enciso Moreno</surname><given-names>JA</given-names></name><name><surname>Gaspar</surname><given-names>RO</given-names></name><name><surname>Trujillo Ochoa</surname><given-names>JL</given-names></name><name><surname>Uresti Rivera</surname><given-names>EE</given-names></name><etal/></person-group>
<article-title>Analysis of Th1, Th17 and regulatory T cells in tuberculosis case contacts</article-title>. <source>Cell Immunol</source> (<year>2014</year>) <volume>289</volume>:<fpage>167</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellimm.2014.03.010</pub-id><?supplied-pmid 24841855?><pub-id pub-id-type="pmid">24841855</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hopewell</surname><given-names>PC</given-names></name></person-group>
<article-title>Clinical Features of Tuberculosis</article-title>. In: <person-group person-group-type="editor"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>van Helden</surname><given-names>P</given-names></name></person-group>, editors. <source>Handbook of Tuberculosis: Clinics, Diagnostics, Therapy and Epidemiology</source>. <publisher-loc>Weinheim</publisher-loc>: <publisher-name>Wiley-VCH Verlag GmbH &#x00026; Co</publisher-name> (<year>2008</year>). p. <fpage>89</fpage>&#x02013;<lpage>114</lpage>.</mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>PK</given-names></name><name><surname>Saha</surname><given-names>PK</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>SK</given-names></name><name><surname>Ghosh</surname><given-names>B</given-names></name><name><surname>Mitra</surname><given-names>DK</given-names></name></person-group>. <article-title>FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2009</year>) <volume>179</volume>:<fpage>1061</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200804-529OC</pub-id><?supplied-pmid 19246720?><pub-id pub-id-type="pmid">19246720</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Almeida</surname><given-names>AS</given-names></name><name><surname>Fiske</surname><given-names>CT</given-names></name><name><surname>Sterling</surname><given-names>TR</given-names></name><name><surname>Kalams</surname><given-names>SA</given-names></name></person-group>. <article-title>Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis</article-title>. <source>Clin Vaccine Immunol</source> (<year>2012</year>) <volume>19</volume>:<fpage>45</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.05263-11</pub-id><?supplied-pmid 22038848?><pub-id pub-id-type="pmid">22038848</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Qin</surname><given-names>XJ</given-names></name><name><surname>Qin</surname><given-names>SM</given-names></name><name><surname>Shi</surname><given-names>HZ</given-names></name></person-group>. <article-title>CCL22 is involved in the recruitment of CD4+CD25 high T cells into tuberculous pleural effusions</article-title>. <source>Respirology</source> (<year>2010</year>) <volume>15</volume>:<fpage>522</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1440-1843.2010.01719.x</pub-id><?supplied-pmid 20337996?><pub-id pub-id-type="pmid">20337996</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geffner</surname><given-names>L</given-names></name><name><surname>Basile</surname><given-names>JI</given-names></name><name><surname>Yokobori</surname><given-names>N</given-names></name><name><surname>Sabio</surname><given-names>YG</given-names></name><name><surname>Musella</surname><given-names>R</given-names></name><name><surname>Castagnino</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>CD4(+) CD25(high) forkhead box protein 3(+) regulatory T lymphocytes suppress interferon-gamma and CD107 expression in CD4(+) and CD8(+) T cells from tuberculous pleural effusions</article-title>. <source>Clin Exp Immunol</source> (<year>2014</year>) <volume>175</volume>:<fpage>235</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1111/cei.12227</pub-id><?supplied-pmid 24134738?><pub-id pub-id-type="pmid">24134738</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>ZJ</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Du</surname><given-names>RH</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>HZ</given-names></name></person-group>. <article-title>Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion</article-title>. <source>Clin Vaccine Immunol</source> (<year>2011</year>) <volume>18</volume>:<fpage>1608</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.05214-11</pub-id><?supplied-pmid 21813663?><pub-id pub-id-type="pmid">21813663</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>ML</given-names></name><name><surname>Tong</surname><given-names>ZH</given-names></name><name><surname>Jin</surname><given-names>XG</given-names></name><name><surname>Zhang</surname><given-names>JC</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name><name><surname>Ma</surname><given-names>WL</given-names></name><etal/></person-group>
<article-title>Regulation of CD4(+) T cells by pleural mesothelial cells via adhesion molecule-dependent mechanisms in tuberculous pleurisy</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e74624</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0074624</pub-id><?supplied-pmid 24069325?><pub-id pub-id-type="pmid">24069325</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Gudetta</surname><given-names>B</given-names></name><name><surname>Fink</surname><given-names>J</given-names></name><name><surname>Granath</surname><given-names>A</given-names></name><name><surname>Ashenafi</surname><given-names>S</given-names></name><name><surname>Aseffa</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions</article-title>. <source>Am J Pathol</source> (<year>2009</year>) <volume>174</volume>:<fpage>2211</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.2353/ajpath.2009.080941</pub-id><?supplied-pmid 19435796?><pub-id pub-id-type="pmid">19435796</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saenz</surname><given-names>B</given-names></name><name><surname>Hernandez-Pando</surname><given-names>R</given-names></name><name><surname>Fragoso</surname><given-names>G</given-names></name><name><surname>Bottasso</surname><given-names>O</given-names></name><name><surname>Cardenas</surname><given-names>G</given-names></name></person-group>. <article-title>The dual face of central nervous system tuberculosis: a new Janus Bifrons?</article-title>
<source>Tuberculosis (Edinb)</source> (<year>2013</year>) <volume>93</volume>:<fpage>130</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2012.11.011</pub-id><?supplied-pmid 23305698?><pub-id pub-id-type="pmid">23305698</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>DB</given-names></name><name><surname>Yong</surname><given-names>YK</given-names></name><name><surname>Tan</surname><given-names>HY</given-names></name><name><surname>Kamarulzaman</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>LH</given-names></name><name><surname>Lim</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis</article-title>. <source>HIV Med</source> (<year>2008</year>) <volume>9</volume>:<fpage>307</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-1293.2008.00565.x</pub-id><?supplied-pmid 18400078?><pub-id pub-id-type="pmid">18400078</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidi</surname><given-names>I</given-names></name><name><surname>Peterson</surname><given-names>K</given-names></name><name><surname>Jeffries</surname><given-names>D</given-names></name><name><surname>Whittle</surname><given-names>H</given-names></name><name><surname>de</surname><given-names>ST</given-names></name><name><surname>Rowland-Jones</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in the Gambia</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e39213</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0039213</pub-id><?supplied-pmid 22745716?><pub-id pub-id-type="pmid">22745716</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddow</surname><given-names>LJ</given-names></name><name><surname>Dibben</surname><given-names>O</given-names></name><name><surname>Moosa</surname><given-names>MY</given-names></name><name><surname>Borrow</surname><given-names>P</given-names></name><name><surname>Easterbrook</surname><given-names>PJ</given-names></name></person-group>. <article-title>Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome</article-title>. <source>AIDS</source> (<year>2011</year>) <volume>25</volume>:<fpage>1163</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1097/QAD.0b013e3283477d67</pub-id><?supplied-pmid 21505297?><pub-id pub-id-type="pmid">21505297</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddiki</surname><given-names>N</given-names></name><name><surname>Sasson</surname><given-names>SC</given-names></name><name><surname>Santner-Nanan</surname><given-names>B</given-names></name><name><surname>Munier</surname><given-names>M</given-names></name><name><surname>van</surname><given-names>BD</given-names></name><name><surname>Ip</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease</article-title>. <source>Eur J Immunol</source> (<year>2009</year>) <volume>39</volume>:<fpage>391</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200838630</pub-id><?supplied-pmid 19180462?><pub-id pub-id-type="pmid">19180462</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boussiotis</surname><given-names>VA</given-names></name><name><surname>Tsai</surname><given-names>EY</given-names></name><name><surname>Yunis</surname><given-names>EJ</given-names></name><name><surname>Thim</surname><given-names>S</given-names></name><name><surname>Delgado</surname><given-names>JC</given-names></name><name><surname>Dascher</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>IL-10-producing T cells suppress immune responses in anergic tuberculosis patients</article-title>. <source>J Clin Invest</source> (<year>2000</year>) <volume>105</volume>:<fpage>1317</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1172/JCI9918</pub-id><?supplied-pmid 10792007?><pub-id pub-id-type="pmid">10792007</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>JC</given-names></name><name><surname>Tsai</surname><given-names>EY</given-names></name><name><surname>Thim</surname><given-names>S</given-names></name><name><surname>Baena</surname><given-names>A</given-names></name><name><surname>Boussiotis</surname><given-names>VA</given-names></name><name><surname>Reynes</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2002</year>) <volume>99</volume>:<fpage>7576</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.062056099</pub-id><?supplied-pmid 12032325?><pub-id pub-id-type="pmid">12032325</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranjbar</surname><given-names>S</given-names></name><name><surname>Ly</surname><given-names>N</given-names></name><name><surname>Thim</surname><given-names>S</given-names></name><name><surname>Reynes</surname><given-names>JM</given-names></name><name><surname>Goldfeld</surname><given-names>AE</given-names></name></person-group>. <article-title><italic>Mycobacterium tuberculosis</italic> recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>:<fpage>1953</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.172.3.1953</pub-id><?supplied-pmid 14734781?><pub-id pub-id-type="pmid">14734781</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hougardy</surname><given-names>JM</given-names></name><name><surname>Place</surname><given-names>S</given-names></name><name><surname>Hildebrand</surname><given-names>M</given-names></name><name><surname>Drowart</surname><given-names>A</given-names></name><name><surname>Debrie</surname><given-names>AS</given-names></name><name><surname>Locht</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Regulatory T cells depress immune responses to protective antigens in active tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2007</year>) <volume>176</volume>:<fpage>409</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200701-084OC</pub-id><?supplied-pmid 17541018?><pub-id pub-id-type="pmid">17541018</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Cassan</surname><given-names>SC</given-names></name><name><surname>Pathan</surname><given-names>AA</given-names></name><name><surname>Sander</surname><given-names>CR</given-names></name><name><surname>Minassian</surname><given-names>A</given-names></name><name><surname>Rowland</surname><given-names>R</given-names></name><name><surname>Hill</surname><given-names>AV</given-names></name><etal/></person-group>
<article-title>Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, <italic>Mycobacterium bovis</italic> BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A</article-title>. <source>Clin Vaccine Immunol</source> (<year>2010</year>) <volume>17</volume>:<fpage>1066</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00047-10</pub-id><?supplied-pmid 20484570?><pub-id pub-id-type="pmid">20484570</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>KL</given-names></name><name><surname>Pathan</surname><given-names>AA</given-names></name><name><surname>Minassian</surname><given-names>AM</given-names></name><name><surname>Sander</surname><given-names>CR</given-names></name><name><surname>Beveridge</surname><given-names>NE</given-names></name><name><surname>Hill</surname><given-names>AV</given-names></name><etal/></person-group>
<article-title>Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel <italic>Mycobacterium tuberculosis</italic> vaccine MVA85A</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>:<fpage>e23463</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0023463</pub-id><?supplied-pmid 21887254?><pub-id pub-id-type="pmid">21887254</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>MB</given-names></name><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Sathler-Avelar</surname><given-names>R</given-names></name><name><surname>Vitelli-Avelar</surname><given-names>DM</given-names></name><name><surname>Spindola-de-Miranda</surname><given-names>S</given-names></name><name><surname>Guimaraes</surname><given-names>TM</given-names></name><etal/></person-group>
<article-title>CD4-CD8-alphabeta and gammadelta T cells display inflammatory and regulatory potentials during human tuberculosis</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e50923</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0050923</pub-id><?supplied-pmid 23239994?><pub-id pub-id-type="pmid">23239994</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson-Sillah</surname><given-names>D</given-names></name><name><surname>Cliff</surname><given-names>JM</given-names></name><name><surname>Mensah</surname><given-names>GI</given-names></name><name><surname>Dickson</surname><given-names>E</given-names></name><name><surname>Sowah</surname><given-names>S</given-names></name><name><surname>Tetteh</surname><given-names>JK</given-names></name><etal/></person-group>
<article-title>Recombinant ESAT-6-CFP10 fusion protein induction of Th1/Th2 cytokines and FoxP3 expressing Treg cells in pulmonary TB</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e68121</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0068121</pub-id><?supplied-pmid 23826366?><pub-id pub-id-type="pmid">23826366</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>XY</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>HB</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>YJ</given-names></name><etal/></person-group>
<article-title>T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients</article-title>. <source>Eur J Clin Microbiol Infect Dis</source> (<year>2010</year>) <volume>29</volume>:<fpage>643</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1007/s10096-010-0908-0</pub-id><?supplied-pmid 20306324?><pub-id pub-id-type="pmid">20306324</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feruglio</surname><given-names>SL</given-names></name><name><surname>Tonby</surname><given-names>K</given-names></name><name><surname>Kvale</surname><given-names>D</given-names></name><name><surname>Dyrhol-Riise</surname><given-names>AM</given-names></name></person-group>. <article-title>Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Clin Exp Immunol</source> (<year>2014</year>) <volume>179</volume>(<issue>3</issue>):<fpage>454</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1111/cei.12468</pub-id><?supplied-pmid 25313008?><pub-id pub-id-type="pmid">25313008</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprengers</surname><given-names>D</given-names></name><name><surname>Stoop</surname><given-names>JN</given-names></name><name><surname>Binda</surname><given-names>RS</given-names></name><name><surname>Kusters</surname><given-names>JG</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Carotenuto</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B</article-title>. <source>Antivir Ther</source> (<year>2007</year>) <volume>12</volume>:<fpage>1087</fpage>&#x02013;<lpage>96</lpage>.<?supplied-pmid 18018767?><pub-id pub-id-type="pmid">18018767</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndure</surname><given-names>J</given-names></name><name><surname>Flanagan</surname><given-names>KL</given-names></name></person-group>. <article-title>Targeting regulatory T cells to improve vaccine immunogenicity in early life</article-title>. <source>Front Microbiol</source> (<year>2014</year>) <volume>5</volume>:<fpage>477</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2014.00477</pub-id><?supplied-pmid 25309517?><pub-id pub-id-type="pmid">25309517</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>TY</given-names></name><name><surname>Waksman</surname><given-names>BH</given-names></name><name><surname>Treffers</surname><given-names>HP</given-names></name></person-group>. <article-title>The thymic suppressor cell. I. Separation of subpopulations with suppressor activity</article-title>. <source>J Exp Med</source> (<year>1974</year>) <volume>139</volume>:<fpage>13</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1084/jem.139.1.13</pub-id><?supplied-pmid 4128445?><pub-id pub-id-type="pmid">4128445</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchant</surname><given-names>A</given-names></name><name><surname>Goetghebuer</surname><given-names>T</given-names></name><name><surname>Ota</surname><given-names>MO</given-names></name><name><surname>Wolfe</surname><given-names>I</given-names></name><name><surname>Ceesay</surname><given-names>SJ</given-names></name><name><surname>de Groote</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Newborns develop a Th1-type immune response to <italic>Mycobacterium bovis Bacillus</italic> Calmette-Guerin vaccination</article-title>. <source>J Immunol</source> (<year>1999</year>) <volume>163</volume>:<fpage>2249</fpage>&#x02013;<lpage>55</lpage>.<?supplied-pmid 10438968?><pub-id pub-id-type="pmid">10438968</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussey</surname><given-names>GD</given-names></name><name><surname>Watkins</surname><given-names>ML</given-names></name><name><surname>Goddard</surname><given-names>EA</given-names></name><name><surname>Gottschalk</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>EJ</given-names></name><name><surname>Iloni</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies</article-title>. <source>Immunology</source> (<year>2002</year>) <volume>105</volume>:<fpage>314</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2567.2002.01366.x</pub-id><?supplied-pmid 11918693?><pub-id pub-id-type="pmid">11918693</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>. <article-title>Tuberculosis vaccines: time to think about the next generation</article-title>. <source>Semin Immunol</source> (<year>2013</year>) <volume>25</volume>:<fpage>172</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.smim.2013.04.006</pub-id><?supplied-pmid 23706597?><pub-id pub-id-type="pmid">23706597</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanekom</surname><given-names>WA</given-names></name></person-group>. <article-title>The immune response to BCG vaccination of newborns</article-title>. <source>Ann N Y Acad Sci</source> (<year>2005</year>) <volume>1062</volume>:<fpage>69</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1196/annals.1358.010</pub-id><?supplied-pmid 16461790?><pub-id pub-id-type="pmid">16461790</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akkoc</surname><given-names>T</given-names></name><name><surname>Aydogan</surname><given-names>M</given-names></name><name><surname>Yildiz</surname><given-names>A</given-names></name><name><surname>Karakoc-Aydiner</surname><given-names>E</given-names></name><name><surname>Eifan</surname><given-names>A</given-names></name><name><surname>Keles</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells</article-title>. <source>Pediatr Allergy Immunol</source> (<year>2010</year>) <volume>21</volume>:<fpage>1059</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1111/j.1399-3038.2010.01051.x</pub-id><?supplied-pmid 20977501?><pub-id pub-id-type="pmid">20977501</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Qiao</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group>. <article-title>The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells</article-title>. <source>Immunobiology</source> (<year>2011</year>) <volume>216</volume>:<fpage>477</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.imbio.2010.09.003</pub-id><?supplied-pmid 20950889?><pub-id pub-id-type="pmid">20950889</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname><given-names>MC</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>. <article-title>CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live <italic>Mycobacterium bovis</italic>-BCG activation of human cells</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>:<fpage>e94192</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0094192</pub-id><?supplied-pmid 24714620?><pub-id pub-id-type="pmid">24714620</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname><given-names>MC</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Bastid</surname><given-names>J</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name></person-group>. <article-title>CD39 is involved in mediating suppression by <italic>Mycobacterium bovis</italic> BCG-activated human CD8(+) CD39(+) regulatory T cells</article-title>. <source>Eur J Immunol</source> (<year>2013</year>) <volume>43</volume>:<fpage>1925</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201243286</pub-id><?supplied-pmid 23606272?><pub-id pub-id-type="pmid">23606272</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>CL</given-names></name><name><surname>Tameris</surname><given-names>M</given-names></name><name><surname>Mansoor</surname><given-names>N</given-names></name><name><surname>van</surname><given-names>RM</given-names></name><name><surname>de</surname><given-names>KM</given-names></name><name><surname>Geldenhuys</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2013</year>) <volume>188</volume>:<fpage>492</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201208-1385OC</pub-id><?supplied-pmid 23306546?><pub-id pub-id-type="pmid">23306546</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumiya</surname><given-names>M</given-names></name><name><surname>Stylianou</surname><given-names>E</given-names></name><name><surname>Griffiths</surname><given-names>K</given-names></name><name><surname>Lang</surname><given-names>Z</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e67922</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0067922</pub-id><?supplied-pmid 23844129?><pub-id pub-id-type="pmid">23844129</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumiya</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>SA</given-names></name><name><surname>Satti</surname><given-names>I</given-names></name><name><surname>Stockdale</surname><given-names>L</given-names></name><name><surname>Tanner</surname><given-names>R</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>MK</given-names></name><etal/></person-group>
<article-title>Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response</article-title>. <source>BMC Infect Dis</source> (<year>2014</year>) <volume>14</volume>:<fpage>314</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2334-14-314</pub-id><?supplied-pmid 24912498?><pub-id pub-id-type="pmid">24912498</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name></person-group>. <article-title>The success and failure of BCG &#x02013; implications for a novel tuberculosis vaccine</article-title>. <source>Nat Rev Microbiol</source> (<year>2005</year>) <volume>3</volume>:<fpage>656</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro1211</pub-id><?supplied-pmid 16012514?><pub-id pub-id-type="pmid">16012514</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>MM</given-names></name><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Mills</surname><given-names>KH</given-names></name></person-group>
<article-title>Editorial: Tregs and BCG &#x02013; dangerous liaisons in TB</article-title>. <source>J Leukoc Biol</source> (<year>2010</year>) <volume>88</volume>:<fpage>1067</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1189/jlb.0710419</pub-id><pub-id pub-id-type="pmid">21123295</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>P</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Seah</surname><given-names>GT</given-names></name></person-group>. <article-title>Regulatory T cells induced by <italic>Mycobacterium chelonae</italic> sensitization influence murine responses to bacille Calmette-Guerin</article-title>. <source>J Leukoc Biol</source> (<year>2010</year>) <volume>88</volume>:<fpage>1073</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0809582</pub-id><?supplied-pmid 20651297?><pub-id pub-id-type="pmid">20651297</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beverley</surname><given-names>P</given-names></name><name><surname>Ronan</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Arnold</surname><given-names>I</given-names></name><name><surname>Bolinger</surname><given-names>B</given-names></name><name><surname>Powrie</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Environmental effects on protection against <italic>Mycobacterium tuberculosis</italic> after immunization with Ad85A</article-title>. <source>Vaccine</source> (<year>2013</year>) <volume>31</volume>:<fpage>1086</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.12.024</pub-id><?supplied-pmid 23262169?><pub-id pub-id-type="pmid">23262169</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>S</given-names></name><name><surname>Hussain</surname><given-names>R</given-names></name><name><surname>Parsonnet</surname><given-names>J</given-names></name></person-group>. <article-title>The impact of mucosal infections on acquisition and progression of tuberculosis</article-title>. <source>Mucosal Immunol</source> (<year>2011</year>) <volume>4</volume>:<fpage>246</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2011.11</pub-id><?supplied-pmid 21412228?><pub-id pub-id-type="pmid">21412228</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Britton</surname><given-names>S</given-names></name><name><surname>Aseffa</surname><given-names>A</given-names></name><name><surname>Engers</surname><given-names>H</given-names></name><name><surname>Akuffo</surname><given-names>H</given-names></name></person-group>. <article-title>Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production</article-title>. <source>Vaccine</source> (<year>2008</year>) <volume>26</volume>:<fpage>3897</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2008.04.083</pub-id><?supplied-pmid 18554755?><pub-id pub-id-type="pmid">18554755</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacan</surname><given-names>G</given-names></name><name><surname>Dang</surname><given-names>H</given-names></name><name><surname>Middleton</surname><given-names>B</given-names></name><name><surname>Horwitz</surname><given-names>MA</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Melega</surname><given-names>WP</given-names></name><etal/></person-group>
<article-title><italic>Bacillus</italic> Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson&#x02019;s disease</article-title>. <source>J Neurosci Res</source> (<year>2013</year>) <volume>91</volume>:<fpage>1292</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1002/jnr.23253</pub-id><?supplied-pmid 23907992?><pub-id pub-id-type="pmid">23907992</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Reinke</surname><given-names>EK</given-names></name><name><surname>Zozulya</surname><given-names>AL</given-names></name><name><surname>Sandor</surname><given-names>M</given-names></name><name><surname>Fabry</surname><given-names>Z</given-names></name></person-group>. <article-title><italic>Mycobacterium bovis</italic> bacille Calmette-Guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>6201</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.9.6201</pub-id><?supplied-pmid 18941210?><pub-id pub-id-type="pmid">18941210</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kang</surname><given-names>MJ</given-names></name><name><surname>Yu</surname><given-names>HS</given-names></name><name><surname>Seo</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><etal/></person-group>
<article-title><italic>Bacillus</italic> Calmette-Guerin suppresses asthmatic responses via CD4(+)CD25(+) regulatory T cells and dendritic cells</article-title>. <source>Allergy Asthma Immunol Res</source> (<year>2014</year>) <volume>6</volume>:<fpage>201</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4168/aair.2014.6.3.201</pub-id><?supplied-pmid 24843794?><pub-id pub-id-type="pmid">24843794</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagranderie</surname><given-names>M</given-names></name><name><surname>Kluge</surname><given-names>C</given-names></name><name><surname>Kiefer-Biasizzo</surname><given-names>H</given-names></name><name><surname>Abolhassani</surname><given-names>M</given-names></name><name><surname>Nahori</surname><given-names>MA</given-names></name><name><surname>Fitting</surname><given-names>C</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium bovis Bacillus</italic> Calmette-Guerin killed by extended freeze-drying reduces colitis in mice</article-title>. <source>Gastroenterology</source> (<year>2011</year>) <volume>141</volume>(<issue>642&#x02013;52</issue>):<fpage>652</fpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2011.05.002</pub-id><?supplied-pmid 21683076?><pub-id pub-id-type="pmid">21683076</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrieu</surname><given-names>JM</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name></person-group>. <article-title>Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8(+) T-regulatory cells that suppress SIV-positive CD4(+) T-cell activation and prevent SIV infection in the macaque model</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>297</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00297</pub-id><?supplied-pmid 25071760?><pub-id pub-id-type="pmid">25071760</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Dwivedi</surname><given-names>VP</given-names></name><name><surname>Maiga</surname><given-names>M</given-names></name><name><surname>Maiga</surname><given-names>M</given-names></name><name><surname>Van</surname><given-names>KL</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name><etal/></person-group>
<article-title>Small molecule-directed immunotherapy against recurrent infection by <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Biol Chem</source> (<year>2014</year>) <volume>289</volume>:<fpage>16508</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M114.558098</pub-id><?supplied-pmid 24711459?><pub-id pub-id-type="pmid">24711459</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Dwivedi</surname><given-names>VP</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Reddy</surname><given-names>MC</given-names></name><name><surname>Kaer</surname><given-names>LV</given-names></name><name><surname>Moodley</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Simultaneous inhibition of T helper 2 and T regulatory cell differentiation by small molecules enhances <italic>Bacillus</italic> Calmette-Guerin vaccine efficacy against tuberculosis</article-title>. <source>J Biol Chem</source> (<year>2014</year>) <volume>289</volume>(<issue>48</issue>):<fpage>33404</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M114.600452</pub-id><?supplied-pmid 25315774?><pub-id pub-id-type="pmid">25315774</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitt</surname><given-names>JM</given-names></name><name><surname>Stavropoulos</surname><given-names>E</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Beebe</surname><given-names>AM</given-names></name><name><surname>Bancroft</surname><given-names>GJ</given-names></name><name><surname>Young</surname><given-names>DB</given-names></name><etal/></person-group>
<article-title>Blockade of IL-10 signaling during <italic>Bacillus</italic> Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>:<fpage>4079</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1201061</pub-id><?supplied-pmid 22972927?><pub-id pub-id-type="pmid">22972927</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhiman</surname><given-names>R</given-names></name><name><surname>Periasamy</surname><given-names>S</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Jaiswal</surname><given-names>AG</given-names></name><name><surname>Paidipally</surname><given-names>P</given-names></name><name><surname>Barnes</surname><given-names>AB</given-names></name><etal/></person-group>
<article-title>NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>:<fpage>897</fpage>&#x02013;<lpage>905</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1102833</pub-id><?supplied-pmid 22711885?><pub-id pub-id-type="pmid">22711885</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaron</surname><given-names>B</given-names></name><name><surname>Maranghi</surname><given-names>E</given-names></name><name><surname>Leclerc</surname><given-names>C</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name></person-group>. <article-title>Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS One</source> (<year>2008</year>) <volume>3</volume>:<fpage>e2833</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0002833</pub-id><?supplied-pmid 18665224?><pub-id pub-id-type="pmid">18665224</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berod</surname><given-names>L</given-names></name><name><surname>Stuve</surname><given-names>P</given-names></name><name><surname>Varela</surname><given-names>F</given-names></name><name><surname>Behrends</surname><given-names>J</given-names></name><name><surname>Swallow</surname><given-names>M</given-names></name><name><surname>Kruse</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>:<fpage>e102804</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0102804</pub-id><?supplied-pmid 25050936?><pub-id pub-id-type="pmid">25050936</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayry</surname><given-names>J</given-names></name><name><surname>Tchilian</surname><given-names>EZ</given-names></name><name><surname>Davies</surname><given-names>MN</given-names></name><name><surname>Forbes</surname><given-names>EK</given-names></name><name><surname>Draper</surname><given-names>SJ</given-names></name><name><surname>Kaveri</surname><given-names>SV</given-names></name><etal/></person-group>
<article-title>In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2008</year>) <volume>105</volume>:<fpage>10221</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0803453105</pub-id><?supplied-pmid 18621704?><pub-id pub-id-type="pmid">18621704</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction</article-title>. <source>Immunol Lett</source> (<year>2009</year>) <volume>122</volume>:<fpage>108</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.imlet.2008.11.007</pub-id><?supplied-pmid 19100777?><pub-id pub-id-type="pmid">19100777</pub-id></mixed-citation></ref></ref-list></back></article>